| ID | CAS | Name | Synonyms | Description |
|---|---|---|---|---|
| 1 | 119302-24-8 | (2b,3a,5a,16b,17b)-17-Acetoxy-3-hydroxy-2-(4-morpholinyl)-16-(1-pyrrolidinyl)androstane | RocuroniuM BroMide InterMediate VIII (2,3,5,16,17)-17-Acetoxy-3-Hydroxy-5-Androstane 2-β-(4-Morpholinyl)-16β-(1-pyrrolidinyl)-5a-androstan-3a,17β-diol-17-acetate 2β-(4-Morpholinyl)-16β-(1-pyrrolidinyl)-5α-androstane-3α,17β-diol 17-acetate (2β,3α,5α,16β,17β)-17-Acetoxy-3-hydroxy-2-(4-morpholinyl)-16-(1-pyrrolidinyl)androstane (2b,3a,5a,16b,17b)-17-Acetoxy-3-hydroxy-2-(4-morpholinyl)-16-(1-pyrrolidinyl)androstane (2B,3A,5A,16B,17B)-17-ACETOXY-3-HYDROXY-2-(4-MORPHOLINYL)-16-(1-PYRROLIDINYL)ANDROSTANE (2β,3α,5α,16β,17β)-3-hydroxy-2-morpholin-4-yl-16-pyrrolidin-1-ylandrostan-17-yl acetate (2b,3a,5a,16b,17b)-2-(4-Morpholinyl)-16-(1-pyrrolidinyl)-androstane-3,17-diol 17-acetate 2beta-(4-Morpholinyl)-16beta-(1-pyrrolidinyl)-5alpha-androstane-3alpha,17beta-diol 17-acetate (2b,3a,5a,16b,17b)-17-Acetoxy-3-hydroxy-2-(4-Morpholinyl)-16-(1-pyrrolidinyl)androstane (2b,3a,5a,16b,17b)-1 | Reference s;Intermediates;Impurity standard;Organic raw materials;Pharmaceutical intermediates;Impurity reference substance;Pharmaceutical raw materials;Rocuronium bromide related intermediates |
| 2 | 139756-22-2 | 5-(5-Chlorosulfonyl-2-ethoxyphenyl)-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one | Sildenafil Chlorosulfone IMpurity Sildenafil Chlorosulfonyl IMpurity 5-(5-CHLOROSULFONYL-2-ETHOXY PHENYL)-1-METHYL-3-N-PROPYL-1 3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1 H-pyrazolo-(4-3-d)-pyrimidine-5 4-Ethoxy-3-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo-[4,3-d]pyrimidin-5-yl)benzene-1-sulfo 5-(5-Chlorosulfonyl-2-ethoxyphenyl)-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one 4-ethoxy-3-(1-methyl-7-oxo-3-propyl-4,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)benzenesulfonyl chloride 3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxy-benzenesulfonyl Chloride 4-Ethoxy-3-(1-Methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyriMidin-5-yl)benzene-1-sulfonyl chloride | Nucleotides;Organic materials;Sulfonyl Chlorides;Hydrocarbon compounds;Bases & Related Reagents |
| 3 | 185104-11-4 | Acotiamide hydrochloride | Z 338 Acotiamide-d6 HCl Acotiamide hydrochloride Acotiamide Hydrochloride Acotiamide dihydrochloride Acetylformamide hydrochloride N-[2-[di(propan-2-yl)amino]ethyl]-2-[(2-hydroxy-4,5-dimethoxybenzoy N-[2-[Bisisopropylamino]-ethyl]-2-[(2-hydroxy-4,5-dimethoxybenzoyl)amino]-4-thiazolecarboxamide HCl N-[2-[Bis(1-methylethyl)amino]ethyl]-2-[(2-hydroxy-4,5-dimethoxybenzoyl)amino]-4-thiazolecarboxamide hydrochloride N-[2-[di(propan-2-yl)amino]ethyl]-2-[(2-hydroxy-4,5-dimethoxybenzoyl)amino]-1,3-thiazole-4-carboxamide,hydrochloride | Inorganic salt;Inorganic Chemical Engineering |
| 4 | 19431-84-6 | Curcumenol | Curcumenol (+)-Curcumenol oil of zedoary turmeric 6H-3a,6-Epoxyazulen-6-ol,1,2,3,4,5,8a-hexahydro- 3,8-dimethyl-5-(1-methylethylidene)-,(3S,3aS,6R,8aS)- 3,8-dimethyl-5-(1-methylethylidene)-1,2,3,4,5,8a-hexahydro-6H-3a,6-epoxyazulen-6-ol (3S,3aS,6R,8aS)-3,8-dimethyl-5-(propan-2-ylidene)-1,2,3,4,5,8a-hexahydro-6H-3a,6-epoxyazulen-6-ol 6H-3a,6-Epoxyazulen-6-ol, 1,2,3,4,5,8a-hexahydro-3,8-dimethyl-5-(1-methylethylidene)-, (3S,3aS,6R,8aS)- (3S,3alphaS,6R,8alphaS)-1,2,3,4,5,8alpha-Hexahydro-3,8-dimethyl-5-(1-methylethylidene)-6H-3alpha,6-epoxyazulen-6-ol | Plant extract;Standard substance;Reference substance;Natural whole grass essential oil;Traditional Chinese medicine reference substance;Reference substance-traditional Chinese medicine reference |
| 5 | 514222-44-7 | Fluconazole Related Compound C | FLUCONAZOLE IMPURITY C Fluconazole Related Compound C Fluconazole USP Related Compound C fluconazole related substance EP C 1,3-Di(1H-1,2,4-triazol-1-yl)benzene 1,1'-(1,3-phenylene)di-1H-1,2,4-triazole 1,1'-(1,3-Phenylene)bis-1H-1,2,4-triazole Fluconazole Impurity 3(Fluconazole EP Impurity C) | Aromatics;Standards;Fluconazole;Heterocycles;Pharmaceuticals;Chemical impurities;Organic intermediates;Impurity reference substance;Intermediates & Fine Chemicals |
| 6 | 536759-91-8 | ethyl 1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate | Apixaban iMpurityG Apixaban impurity BMS-589154 Ethyl 1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3 4,5,6,7-Tetrahydro-1-(4-Methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-1H-pyrazolo[3,4-c]pyridine-3-carboxyl ethyl 1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate ethyl 1-(4-Methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate 1H-Pyrazolo[3,4-c]pyridine-3-carboxylicacid,4,5,6,7-tetrahydro-1-(4-Methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-,ethylester 4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl este 4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester 4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester 1H-Pyrazolo[3,4-c]pyridine-3-carboxylic acid, 4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-, ethyl ester | Organic materials;Organic acid esters |
| 7 | 608142-27-4 | (R)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethanamine | Apremilast Impurity 83 Apremilast Impurity 58 Apremilast impurity HS093231 -?[(methylsulfonyl)?methyl]?-benzenemethanamine (R)-1-(3-Ethoxy-4-Methoxyphenyl)-2-(Methylsulfonyl)ethylaMine (R)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethanamine (R)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethanamine Benzenemethanamine, 3-ethoxy-4-methoxy-α-[(methylsulfonyl)methyl]-, (αR)- (alphaR)-3-Ethoxy-4-methoxy-alpha-[(methylsulfonyl)methyl]benzenemethanamine | Organic materials;Hydrocarbon compounds |
| 8 | 6261-22-9 | pent-2-yn-1-ol | AI3-37254 2-Pentyn-1-ol 2-pentyn-1-0l 1-pentyn-1-ol 2-PENTYN-1-OL 2-PENTYNE-1-OL pent-2-yn-1-ol | Alkynes;Internal;Alcohols;Acetylenes;Building Blocks;Organic materials;Chemical Synthesis;Organic Building Blocks;Organic Building Blocks;Acetylenic Alcohols & Their Derivatives |
| 9 | 357336-99-3 | Brivaracetam (alfaR, 4S)-Isomer | Brivaracetam (alfaR Brivaracetam Impurity B Brivaracetam Impurity 3 Boisirtam (alfaR, 4S) isomer Brivaracetam (alfaR, 4S)-Isomer (R)-2-((S)-2-oxo-4-propylpyrrolidin-1-yl)butanamide 2R-2-[(4S)-2-oxo-4-propylpyrrolidin-1-yl]butanamide 1-Pyrrolidineacetamide, α-ethyl-2-oxo-4-propyl-, (αR,4S)- | Impurity;Buvaracetam;Buvaracetam impurity;Brivaracetam impurity;Impurity control article;Control article-impurity control article |
| 10 | 129212-35-7 | 8-EpitacroliMus | 8-EpitacroliMus Tacrolimum 8-Epimer Tacrolmius 8-epimer Tacrolimus Impurity 1(Tacrolimus 8-Epimer) Tacrolimus EP Impurity D (8-epi Tacrolimus) Tacrolimus Impurity 1(Tacrolimus EP Impurity D)(Tacrolimus 8-Epimer) [3S-[3R*[E(1S*,3S*,4S*)],4S*,5R*,8R*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26aR*]]- 5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-Hexadecahydro-5,19-dihydroxy-3-[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-pro | Tacrolimus impurities;Chiral Reagents, Pharmaceuticals, mediates & Fine Chemicals;Chiral Reagents, Pharmaceuticals, Intermediates & Fine Chemicals |
| 11 | 50739-76-9 | 2-AMINO-3,5-DIBROMOBENZYL ALCOHOL | RARECHEM AL BD 0466 3,5-Dibromo-2-amino BroMhexine EP IMpurity A 2-AMINO-3,5-DIBROMOBENZYL ALCOHOL 3,5-DIBROMO-2-AMINO BENZYL ALCOHOL 2-Amino-3,5-dibromo-benzenemethanol BenzeneMethanol, 2-aMino-3,5-dibroMo- 2-AMino-3,5-dibroMobenzyl benzoic alcohol | Amines;Aromatics;Miscellaneous Reagents |
| 12 | 547-75-1 | HYOCHOLIC ACID | HYOCHOLIC ACID GAMMA MURICHOLIC LAMBDA-MURICHOLIC ACID 5B-CHOLAN-24-OIC ACID-3A,6A,7A-TRIOL 3A,6A-7A-TRIHYDROXY-5B-CHOLAN-24-OIC ACID 5-BETA-CHOLAN-24-OIC ACID-3-ALPHA,6-ALPHA,7-ALPHA-TRIOL 3-ALPHA,6-ALPHA,7-ALPHA-TRIHYDROXY-5-BETA-CHOLAN-24-OIC ACID 3,6,7-trihydroxy-,(3alpha,5beta,6alpha,7alpha)-cholan-24-oicaci | Raw material;Food additive;Impurity reference substance |
| 13 | 604-19-3 | 4-PREGNEN-6-BETA-OL-3,20-DIONE | U 27605 sMallest 4-Pregnen-6β-ol-3,20-dione 6-BETA-HYDROXYPROGESTERONE 4-PREGNEN-6-BETA-OL-3,20-DIONE 6β-Hydroxypregn-4-en-3,20-dione 6β-Hydroxypregn-4-ene-3,20-dione 6-beta-Hydroxypregn-4-ene-3,20-dione | Steroids;Pharmaceuticals;Metabolites & Impurities;Intermediates & Fine Chemicals |
| 14 | 2513-33-9 | 2-(2,4-DIHYDROXYBENZOYL)BENZOIC ACID | 2-(2,4-DIHYDROXYBENZOYL)BENZOIC ACID 2-(2,4-DIHYDROXYBENZOYL)BENZOIC ACID Benzoic acid,2-(2,4-dihydroxybenzoyl)- 2-(2,4-dihydroxyphenyl)carbonylbenzoic acid Aspirin IMpurity (2-(2,4-Dihydroxybenzoyl)benzoic Acid) (2 -(2,4-Dihydroxybenzoyl)) Aspirin IMpurity (2-(2,4-Dihydroxybenzoyl)benzoic Acid) | Aromatics;Pharmaceuticals;Intermediates & Fine Chemicals |
| 15 | 1416134-48-9 | Avibactam INT 1 | Avibactam IM-1 Avibactam INT 1 Avibactam-002-oxalate Avibactam Intermediate Avivabine sodium intermediate 1 ethyl(2S,5R)-5-((benzyloxy)amino)piperdine-2-carboxylate oxalate (2S, 5R) -benzyloxyaminopiperidine-2-carboxylic acid ethyl oxalate (2S,5R)-Methyl-5-[(benzyloxy)amino]piperidine-2-carboxylate ethanedioate | Shaanx;intermediate;Intermediates;Chemical industry;Bioactive molecules;Beta lactamase inhibitor;Impurity reference substance;Avibactam sodium intermediate 1;Reference substance-impurity reference sub |
| 16 | Bromhexine Glucose Compound 1 | Bromhexine Glucose Compound 1 | Impurity reference substance | |
| 17 | 2452301-14-1 | Empagliflozin Impurity POE | Empagliflozin Impurity POE | Impurity reference substance |
| 18 | Bromhexine Glucose Compound 2 | Bromhexine Glucose Compound 2 | Impurity reference substance | |
| 19 | 766480-48-2 | LCZ 696 Impurity B | LCZ 696 Impurity B (2R,4R)-Sacubitril Sacubitril Impurity B Sacubitril Impurity 24 LCZ-696 Impurity 7 calcium salt Sacubitril-(2R, 4R)-Isomer Calcium Salt [1,1'-Biphenyl]-4-pentanoic acid, γ-[(3-carboxy-1-oxopropyl)amino]-α-methyl-, 4-ethyl ester, (αR,γR)-rel- | Intermediates-Pharmaceutical Intermediates |
| 20 | 761373-05-1 | ahu377 isomer 2 | ahu377 isomer 2 ahu377 isomer 2 2R,4S-Sacubitril LCZ 696 Impurity A LCZ 696 Impurity A Sacubitril Enantiomer Sacubitril (2S,4R)-Isomer 4-(((2R,4S)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy-4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoic acid [1,1'-Biphenyl]-4-pentanoic acid, γ-[(3-carboxy-1-oxopropyl)amino]-α-methyl-, 4-ethyl ester, (αS,γR)- (alphaS,gammaR)-gamma-[(3-Carboxy-1-oxopropyl)amino]-alpha-methyl-[1,1'-biphenyl]-4-pentanoic acid 4-ethyl ester | 032-LCZ696;Intermediates-Pharmaceutical Intermediates |
| 21 | 1686149-74-5 | BMS-589154 | BMS-724914 BMS-778960 BMS-719288 BMS-591329 BMS-589154 BMS-728626 BMS-589154) Apixaban iMpurity(BMS-591455 | Impurity reference substance |
| 22 | 17460-13-8 | deoxyfructosazine | NSC 270912 deoxyfructosazine 2-(D-arabino-Tetrahydroxybutyl)-5-(D-erythro-2,3,4-trihydroxybutyl)pyrazine (1R,2S,3R)-1-[5-[(2S,3R)-2,3,4-Trihydroxybutyl]pyrazin-2-yl]-1,2,3,4-butanetetrol (1R,2S,3R)-1-[5-[(2S,3R)-2,3,4-Trihydroxybutyl]-2-pyrazinyl]-1,2,3,4-butanetetrol | Aromatics;Carbohydrates & Derivatives |
| 23 | 19532-98-0 | Milnacipran Related Impurity 3 | OMAD-007 Minapram Impurity 3 Lafutidine Impurity 12 N,N-Dimethylphthalamide N1,N2-dimethylphthalamide Milnacipran Related Impurity 3 N1,N2-Dimethyl-1,2-benzenedicarboxamide 1-N,2-N-dimethylbenzene-1,2-dicarboxamide | amide;Impurity reference substance |
| 24 | 10141-72-7 | 2-METHYLTETRAHYDROPYRAN | methylterahydropyran 2-METHYLTETRAHYDROPYRAN Tetrahydro-2-methylpyran TETRAHYDRO-2-METHYL-2H-PYRAN (R,S)-2-Methyl-tetrahydro-pyran | Reference substance-impurity reference substance |
| 25 | 171596-43-3 | (1S,3S)-1-(1,3-Benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Methyl Ester | Tadalafil-015-1S3S Tadanafil Impurity 1 Tadalafil Impurity 32 Tadalafil Related Impuirty 6 Methyl (1S,3S)-1-(1,3-benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-β-c arboline-3-carboxylate (1S,3S)-1-(1,3-Benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Methyl Ester (1S-cis)-1-(1,3-benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Methyl Ester | Inhibitors;Chiral Reagents |
| 26 | AMlodipine iMpurity | AMlodipine iMpurity Amlodipine Impurity A,D,H,G | Impurity reference substance | |
| 27 | 5302-45-4 | β-n-oxalylamino-l-alanine | ODAP β-L-ODAP Dencichin β-n-oxalylamino-l-alanine BETA-N-OXALAMINO-L-ALANINE BETA-N-OXYALYLAMINE-L-ALANINE 3-N-OXALYL-L-2,3-DIAMINOPROPANOICACID BETA-N-OXALYL-ALPHA,BETA-DIAMINOPROPIONICACID (S)-2-Amino-3-[(1,2-dioxo-2-hydroxyethyl)amino]propionic acid | Plant extract;Reference subst;Standard substance;Reference substance;Analytical reagent standard substance;Standard substance-reference substance;Traditional Chinese medicine reference substance |
| 28 | 57423-71-9 | physalin F | physalin F | Flavonoids;Traditional Chinese medicine reference substance |
| 29 | 49694-21-5 | Xylohexaose | Xylohexaose 1,4-b-D-Xylohexaose D-Xylose, O-β-D-xylopyranosyl-(1→4)-O-β-D-xylopyranosyl-(1→4)-O-β-D-xylopyranosyl-(1→4)-O-β-D-xylopyranosyl-(1→4)-O-β-D-xylopyranosyl-(1→4)- O-beta-D-Xylopyranosyl-(1-4)-O-beta-D-xylopyranosyl-(1-4)-O-beta-D-xylopyranosyl-(1-4)-O-beta-D-xylopyranosyl-(1-4)-O-beta-D-xylopyranosyl-(1-4)-D-xylose | Sugar chemical analysis standard |
| 30 | 83883-10-7 | Hydroxy-alpha-Sanshool | (2E,6Z,8E,10E) Hydroxy-α-sanshool Hydroxy-alpha-Sanshool alpha-Hydroxy-Sanshool dodeca-2,6,8,10-tetraenamide -N-(2-Hydroxy-2-methylpropyl) (2E,6Z,8E,10E)-N-(2-hydroxy-2-Methylpropyl)dodeca-2,6,8,10-tetra | Reference substance;Standard substance-reference substance;Standard substance, reference substance |
| 31 | 53625-15-3 | Teucvidin | tencvidin Teucvidin NSC 258599 (3R,5S,5'aR)-5-(3-Furyl)-3',4,5,5',5'aα,7',8',8'aα-octahydro-7'α-methylspiro[furan-3(2H),6'-[6H]naphtho[1,8-bc]furan]-2,2'(4'H)-dione (3R,5S,5'aR,7'R,8'aR)-5-(3-Furanyl)-3',4,5,5',5'a,7',8',8'a-octahydro-7'-methylspiro[furan-3(2H),6'-[6H]naphtho[1,8-bc]furan]-2,2'(4'H)-dione Spiro[furan-3(2H),6'-[6H]naphtho[1,8-bc]furan]-2,2'(4'H)-dione, 5-(3-furanyl)-3',4,5,5',5'a,7',8',8'a-octahydro-7'-methyl-, (3R,5S,5'aR,7'R,8'aR)- | Diterpene;Reference substance;Fine chemical industry;Reference substance-traditional Chinese medicine reference substance |
| 32 | 55446-15-6 | Araloside C | Araloside C | |
| 33 | 52793-97-2 | Camphor Benzalkonium Methosulfate | Camphor Benzalkonium Methosulfat Camphor Benzalkonium Methosulfate 4-(2-OXO-3-BORNYLIDENEMETHYL)PHENYLTRIMETHYLAMMONIUMMET. 4-((2-oxo-3-bornylidene)methyl)-phenyltrimethylammonium methylsulfate 4-[(2-oxo-3-bornylidene)-methyl]-phenyltrimethylammonium methylsulphate methyl N,N,N-trimethyl-4-[(4,7,7-trimethyl-3-oxobicyclo[2.2.1]hept-2-ylidene)methyl]anilinium sulphate Benzenaminium, N,N,N-trimethyl-4-((4,7,7-trimethyl-3-oxobicyclo(2.2.1)hept-2-ylidene)methyl)-, methyl sulfate (Z)-N,N,N-trimethyl-4-((4,7,7-trimethyl-3-oxobicyclo[2.2.1]heptan-2-ylidene)methyl)benzenaminium methyl sulfate | Standard |
| 34 | 1092578-46-5 | (3R,4S)-Tofacitinib | (3R,4S)-Tofacitinib Tofacitinib IMpurity E RS-tofacitinib citirate Tofacitinib Impurity A(3R,4S) (3R,4S)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-1-piperidinepropanenitrile (3R,4S)-4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-beta-oxo-1-piperidinepropanenitrile 1-Piperidinepropanenitrile, 4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-β-oxo-, (3R,4S)- 3-((3R,4S)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile | Impurity reference substance;toffatinib impurity reference substance;reference substance-impurity reference substance;chemical reagents, fine chemicals, pharmaceutical intermediates, material inter |
| 35 | 63284-72-0 | Citalopram N-Oxide | Lu 11-305 Citalopram N-Oxide Citalopram Impurity 11 Citalopram USP RC E(Base) Dimethyl[3-[1-(4-fluorophenyl)-5-cyano-1,3-dihydroisobenzofuran-1-yl]propyl]amine N-oxide 1-[3-(Dimethyloxidoamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro -5-isobenzofurancarbonitrile 1-(4-Fluorophenyl)-1-[3-(dimethyl oxide amino)propyl]-1,3-dihydroisobenzofuran-5-carbonitrile 1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile N1-Oxide | Heterocycles;Escitalopram;229-escitalopram;Heterocyclic Compounds;Metabolites & Impurities |
| 36 | 141626-57-5 | N-(2-butyl-3-(4-(3-(dibutylamino)propoxy)-benzoyl)benzofuran-5-yl)-N-(methylsulfonyl)methanesulfonamide | Dronedarone EP Impurity C HCl Dronedarone Hydrochloride Impurity B HCl Dronedarone Hydrochloride Related Compound B N-(2-BUTYL-3-(4-(3-(DIBUTYLAMINO)PROPOXY)-BENZOYL)BENZOFURAN-5-YL)-N-(METHYLSULFONYL)METHANESULFONAM N-(2-butyl-3-(4-(3-(dibutylamino)propoxy)-benzoyl)benzofuran-5-yl)-N-(methylsulfonyl)methanesulfonamide N-[2-butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]-1-benzofuran-5-yl]-N-methylsulfonylmethanesulfonamide Methanesulfonamide, N-[2-butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]-5-benzofuranyl]-N-(methylsulfonyl)- | Impurity reference substance-jonadalone |
| 37 | 201530-78-1 | Deferasirox Impurity 8 | Deferasirox Impurity 8 Deferasirox EP Impurity C Deferasirox Phase 1 impurity 2-[3,5-Bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]benzoic Acid Benzoic acid, 2-[3,5-bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]- | Impurity reference substance |
| 38 | 629652-72-8 | ent-Tadalafil | ent-Tadalafil (S,S)-Tadalafil Tadanafil EP or USP impurity B Tadalafil Impurity B (ent-tadalafil) Tadalafil EP Impurity B ((6S,12S)-Tadalafil) | Inhibitors;240-tadalafir;Chiral Reagents;Pharmaceuticals;Impurity reference substance;Intermediates & Fine Chemicals |
| 39 | 27480-30-4 | Lincomycin 2-Phosphate | Lincomycin 2-Phosphate LincoMycin 2-Phosphate Clindamycin Impurity G (2R,3R,4S,5R,6R)-4,5-dihydroxy Clindamycin Phosphate EP Impurity F Clindamycin phosphate Impurity F(Lincomycin 2-Phosphate) Lincomycin 2-Phosphate, Clindamycin phosphate Impurity F Clindamycin Impurity 15(Clindamycin Phosphate EP Impurity F) methyl 6,8-dideoxy-6-[[[(2S,4R)-1-methyl-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-D-erythro-α-D-galacto-Octopyranoside 2-(dihydrogen phosphate) | Standard substance;Impurity reference substance;Clindamycin phosphate impurity;Reference substance-impurity reference substance |
| 40 | 56750-04-0 | Metronidazole Impurity 10 | Metronidazole Impurity 10 Secnidazole 1-Propanol Analog β,2-Dimethyl-5-nitro-1H-imidazole-1-ethanol 1H-Imidazole-1-ethanol, β,2-dimethyl-5-nitro- 2-(2-methyl-5-nitro-imidazol-1-yl)-propan-1-ol 1-(3-hydroxyisopropyl)-2-methyl-5-nitroimidazole 1-((2-Hydroxy-1-methyl)ethyl)-2-methyl-5-nitroimidazole | impurity reference substance;Reference substance-impurity reference substance |
| 41 | 246038-13-1 | 17α-Dydrogesterone | 17α-Dydrogesterone Dydrogesterone Impurity 2 9β,10α,17α-Pregna-4,6-diene-3,20-dione Pregna-4,6-diene-3,20-dione, (9β,10α,17α)- (9CI) (8S,9R,10S,13S,14S,17R)-17-acetyl-10,13-dimethyl-1,2,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one | Impurity reference substance |
| 42 | 97164-56-2 | (E)-Cefixime (Cefixime EP Impurity D) | CefixiMe E-isoMer Cefixime EP impurity D (E)-Cefixime (Cefixime EP Impurity D) (E)-CefixiMe (CefixiMe EP IMpurity D) Cefixime Impurity 4(Cefixime EP Impurity D) Cefixime Impurity D (EP) (Cefixime E-isomer ) [6R-[6α,7β(E)]]-7-[[(2-AMino-4-thiazolyl)[(car (6R,7R)-7-((E)-2-(2-aminothiazol-4-yl)-2-((carboxymethoxy)imino)acetamido)-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (6R,7R)-7-[[(2E)-2-(2-AMino-4-thiazolyl)-2-[(carboxyMethoxy)iMino]acetyl]aMino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid | Ph;Impurities;Heterocycles;Pharmaceuticals;Cefixime advantage supply;Sulfur & Selenium Compounds;Impurity reference substance;Intermediates & Fine Chemicals;Cefixime impurity advantage supply;Referenc |
| 43 | 67022-39-3 | Methotrexate γ-Methyl Ester | Methotrexate Impurity H Methotrexate EP Impurity H Methotrexate γ-Methyl Ester Methotrexate Impurity 8(EP-H) Methotrexate-5-monomethyl ester Methotrexate γ-Methyl Ester (Impurity H) Methotrexate EP Impurity H (Methotrexate-5-Monomethyl Ester) (2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]-5-methoxy-5-oxopentanoic acid | Impurity reference substance;Aromatics, Chiral Reagents, Heterocycles, Nucleotides, Bases & Related Reagents, Pharmaceuticals, Intermediates & Fine Chemicals |
| 44 | 1190105-63-5 | 3-Acetyl-17-deacetyl Rocuronium Bromide | Rocuronium impurity D Rocuronium EP Impurity D Rocuronium bromide EP impurity D 3-Acetyl-17-deacetyl Rocuronium Bromide 3-Acetyl-17-deacetyl RocuroniuM BroMide Rocuronium Bromide EP Impurity D Bromide Rocuronium Bromide Impurity 4(EP Impurity D) RocuroniuM BroMide IMpurity 17 (EP iMpurity D) 1-[3α-acetoxy-17β-hydroxy-2β-(morpholin-4-yl)-5α-androstan-16β-yl]-1-(prop-2-enyl)pyrrolidinium | Impurity standard substance;Rocuronium bromide impurity;Impurity reference substance;Reference substance-impurity reference substance;Heterocycles, Impurities, Pharmaceuticals, Intermediates & Fin;Het |
| 45 | 119302-86-2 | 17-Desacetyl Rocuronium Bromide | ORG 9943 17-Desacetyl Rocuronium Rocuronium EP Impurity C 17-Desacetyl Rocuronium Bromide Rocuronium Bromide Impurity 3(EP Impurity C) RocuroniuM BroMide Related CoMpound C (EP iMpurity C) 1-[3α,17β-dihydroxy-2β-(morpholin-4-yl)-5α-androstan-16β-yl]-1-(prop-2-enyl)pyrrolidinium Bromide 1-[(2β,3α,5α,16β,17β)-3,17-Dihydroxy-2-(4-Morpholinyl)androstan-16-yl]-1-(2-propenyl)pyrrolidiniuM BroMide | Metabol;Steroids;Heterocycles;Pharmaceuticals;Impurity standard;Reference substance;Metabolites & Impurities;Rocuronium bromide impurity;Impurity reference substance;Intermediates & Fine Chemicals |
| 46 | 97240-80-7 | TopiraMate N-Methyl IMpurity | N-Methyl TopiraMate Topiramate Impurity 11 LDHJVCCWWXVXBN-DNJQJEMRSA-N TopiraMate N-Methyl IMpurity N-methyl Topiramate Impurity | Topiramate impurity |
| 47 | 66340-33-8 | 3-Desacetyl Cefotaxime Lactone | Ceftriaxone IMpurity B Cefotaxime EP Impurity B CefotaxiMe Related CoMpound E 3-Desacetyl Cefotaxime Lactone 3-Desacetyl CefotaxiMe Lactone 3-Desacetyl CefotaxiMe Lactone (IMpurity E) Deacetylcefotaxime lactone ,Cefotaxime Impurity E (EP) Ceftriaxone Sodium EP Impurity B(Cefotaxime EP Impurity E) [5aR-[5aα,6β(Z)]]-2-AMino-α-(MethoxyiMino)-N-(1,4,5a,6-tetrahydro-1,7-dioxo-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl)-4-thiazoleacetaMide | Amines;Impurity;Impurities;Cefotaxime;Heterocycles;Pharmaceuticals;Ceftriaxone sodium;Ceftriaxone impurities;Intermediates & Fine Ch;Sulfur & Selenium Compounds |
| 48 | 6736-40-9 | N-Methyl-5-methylamino-1H-imidazole-4-carboxamide | Theophyllidine Diprophylline EP Impurity A N-Methyl-5-(methylamino)-1H-imidazo N-Methyl-5-methylamino-1H-imidazole-4-carboxamide N-Methyl-4-(Methylamino)-1H-Imidazole-5-Carboxamide 1H-Imidazole-4-carboxamide, N-methyl-5-(methylamino)- N-Methyl-5-(methylamino)-1H-imidazole-4-carboxamide (Theophyllidine) | impurity reference substance;Reference substance-impurity reference substance |
| 49 | 911-77-3 | N-Benzoyl-DL-arginine-4-nitroanilide hydrochloride | N-ALPHA-BENZOYL-DL-ARGININE-4-NITROANILIDE HCL N-Benzoyl-DL-arginine-4-nitroanilide hydrochloride N-A-BENZOYL-DL-ARGININE-P-NITROANILIDEHY DROCHLORID N-α-Benzoyl-DL-arginine 4-nitroanilide hydrochloride N-ALPHA-BENZOYL-DL-ARGININE-4-NITROANILIDE HYDROCHLORIDE ALPHA-N-BENZOYL-DL-ARGININE-P-NITROANILIDE HYDROCHLORIDE N-ALPHA-BENZOYL-DL-ARGININE 4-NITROANILIDE MONOHYDROCHLORIDE | substrate |
| 50 | 2056261-41-5 | BRD0705 | BRD0705 BRD0705 (BRD-0705 | aromatic |
| 51 | 685886-82-2 | Potassium 2-(1-hydroxypentyl)benzoate | 380905-48-6 (free) n-Butylphthalide-025-K Butylphthalide impurity Butylphthalide Impurity 25 3-Butylphthalide Impurity E potassium 2-(1-hydroxypentyl)benzoate Potassium 2-(1-hydroxypentyl)benzoate Butylphthalide Impurity 26 Potassium Salt Potassium-Hydroxypentyl Benzoate 685886-82-2 | |
| 52 | 884330-12-5 | 6-Des(1-Methyl-2-benziMidazolyl)-6-carboxy TelMisartan | Tenofovir (S)-Isomer TelMisartan EP IMpurity E TelMisartan Diacid IMpurity Telmisartan Impurity 5(Telmisartan EP Impurity E) 6-Des(1-Methyl-2-benziMidazolyl)-6-carboxy TelMisartan 1-[(2'-Carboxy[1,1'-biphenyl]-4-yl)Methyl]-4-Methyl-2-propyl-1H-benziMidazole-6-carboxylic Acid 1H-BenziMidazole-6-carboxylic acid, 1-[(2'-carboxy[1,1'- biphenyl]-4-yl)Methyl]-4-Methyl-2-propyl- 1-((2'-Carboxy-[1,1'-biphenyl]-4-yl)methyl)-4-methyl-2-propyl-1H-benzo[d]imidazole-6-carboxylic acid | Aromatics;Impurities;Heterocycles;Pharmaceuticals;Impurity reference substance;Intermediates & Fine Chemicals;Reference substance-impurity reference substance |
| 53 | 168110-44-9 | FR 179642 | FR 179642 Micafungin Nucleus Micafungin FR-179642 N-1 Micafungin Sodium Micafungin Impurity 10 Micafungin Impurity FR-179642 Micafungin FR-179642 IMpurity Micafungin FR-179642 impurity (acid) | Pharmaceutical Intermediates |
| 54 | 149709-63-7 | LCZ 696 Impurity C | (2S,4S)-Sacubitril LCZ 696 Impurity C Sacubitril Impurity C 4-(((2S,4S)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy-4-methyl-5-oxopentan-2-yl)amino)-4-oxobutanoic acid 1,1'-Biphenyl]-4-pentanoic acid, γ-[(3-carboxy-1-oxopropyl)amino]-α-methyl-, α-ethyl ester, (αS,γS)- [1,1'-Biphenyl]-4-pentanoic acid, γ-[(3-carboxy-1-oxopropyl)amino]-α-methyl-, α-ethyl ester, (αS,γS)- [1,1'-Biphenyl]-4-pentanoic acid, γ-[(3-carboxy-1-oxopropyl)amino]-α-methyl-, ethyl ester, [S-(R*,R*)]- (9CI) | Impurity reference substance;Reference substance-standard substance |
| 55 | 217448-86-7 | 4-Descarboxamido Rufinamide 4-Methyl Ester | Rufinamide EP Impurity B Rufinamide 4-Methyl Ester RufinaMide Related CoMpound B Rufinamide USP Related Compound B 4-Descarboxamido Rufinamide 4-Methyl Ester methyl 1-[(2,6-difluorophenyl)methyl]triazole-4-carboxylate Methyl 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate 1-[(2,6-difluorophenyl)methyl]-1H-1,2,3-Triazole-4-carboxylic acid methyl ester Rufinamide Related Compound B (25 mg) (Methyl 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate) | Impurity reference substance |
| 56 | 1859141-26-6 | 1-((2-((2-((7-chloroquinolin-4-yl)amino)ethyl)(methyl)amino)ethyl)amino)-4-methyl-9H-thioxanthen-9-one | ROC325 ROC 325 ROC-325 1-((2-((2-((7-chloroquinolin-4-yl)amino)ethyl)(methyl)amino)ethyl)amino)-4-methyl-9H-thioxanthen-9-one 9H-Thioxanthen-9-one, 1-[[2-[[2-[(7-chloro-4-quinolinyl)amino]ethyl]methylamino]ethyl]amino]-4-methyl- | Standard substance;Reference substance |
| 57 | 909779-33-5 | Levocetirizine Amide | Levocetirizine Amide Cetirizine Impurity 47 Levocetirizine Amide (USP) Levocetirizine Amide impurity Levocetirizine amide impurity HCl 2-[2-[4-[(R)-(4-Chlorophenyl)phenylmethyl]-1-iperazinyl]ethoxy]-acetamide (R)-2-(2-(4-((4-chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)acetamide Acetamide, 2-[2-[4-[(R)-(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]- 2-?[2-?[4-?[(R)?-?(4-?Chlorophenyl)?phenylmethyl]?-?1-?piperazinyl]?ethoxy]?-acetamide | impurity reference substance;Reference substance-impurity reference substance |
| 58 | 141392-23-6 | Rapamycin, 32-O-demethyl- | 32-O-Demethyl-rapamycin Rapamycin, 32-O-demethyl- Rapamycin, 32-O-demethyl- (9CI) 32-O-Demethyl-rapamycin DISCONTINUED | |
| 59 | 173101-55-8 | BUTYL ANALOG OF TAXOL, n-(RG) | n-Butyl analog Paclitaxel Impurity 95 BUTYL ANALOG OF TAXOL, n-(RG) | Raw material |
| 60 | 16711-91-4 | 11-Keto Fusidic Acid | 11-Keto Fusidic Acid 11-Ketofusidinsaeure 11-monoketofusidic acid Fusidic Acid Impurity H Fusidic Acid BP ImpurityH Fusidic Acid EP Impurity H (3α,4α,8α,9β,13α,14β,16β,17Z)-16-(Acetyloxy)-3-hydroxy-11-oxo- | Steroids;Pharmaceuticals;Metabolites & Impuritie;Metabolites & Impurities;Impurity reference substance;Intermediates & Fine Chemicals;Chemical impurity-fusidic acid;Metabolites & Impurities, Pharmaceu |
| 61 | 641571-15-5 | 4-Methyl-N-(3-(5-Methyl-1H-iMidazol-1-yl)-5-(trifluoroMethyl)phenyl)-3-((4-(pyridin-3-yl)pyriMidin-2-yl)aMino)benzaMide | NILOTINIB IMPURITY 9 NILOTINIB REGIO ISOMER Nilotinib Regio Isomer 4-Methyl-N-(3-(5-Methyl-1H-iMidazol-1-yl)-5-(trifluoroMethyl)phenyl)-3-((4-(pyridin-3-yl)pyriMidin-2-yl)aMino)benzaMide | Bioactive molecules;Impurity reference substance |
| 62 | 17592-07-3 | (3beta,6E)-9,10-secocholesta-5(10),6,8-trien-3-ol | Tachysterol 3 Einecs 241-561-3 (6E)-9,10-Secocholesta-5(10),6,8-trien-3β-ol (3beta,6E)-9,10-secocholesta-5(10),6,8-trien-3-ol 9,10-Secocholesta-5(10),6,8-trien-3-ol,(3.beta.,6E) 9,10-Secocholesta-5(10),6,8-trien-3-ol, (3.beta.,6E) (1S)-3-[(E)-2-[(1R,3aR,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-1,2,3,3a,6,7-hexahydroinden-4-yl]ethenyl]-4-methyl-cyclohex-3-en-1-ol | Standard;Impurities;150-vitamin D3;Impurity reference substance |
| 63 | 1094463-26-9 | IMidazo[1,2-a]pyridin-6-aMine, 3-chloro- | 3-chloro-Imidazo[1,2-a]pyridin-6-amine 6-AMino-3-chloroiMidazo[1,2-a]pyridine IMidazo[1,2-a]pyridin-6-aMine, 3-chloro- | |
| 64 | 61445-55-4 | N-Nitroso-N-methyl-4-aminobutyric Acid | NMBA Losartan Impurity 17 4-(methylnitrosoamino)-butyricaci 4-(N-NITROSOMETHYLAMINO)BUTYRICACID 4-(Methylnitrosoamino)butanoic acid N-Nitroso-N-methyl-4-aminobutyric Acid 4-(n-nitroso-n-methylamino)butyricacid n-methyl-n-(3-carboxypropyl)nitrosamine | Impurity reference substance |
| 65 | 104632-28-2 | Dexpramipexole | DexpraMipexole Dexpramipexole (R)-Pramipexole R-(+)-Pramipexole (R)-Pramipexole Dihydrochloride R-(+)-Pramipexole Dihydrochloride (R)-4,5,6,7-Tetrahydro-N6-propyl-2,6-benzothiazolediamine (R)-4,5,6,7-Tetrahydro-N6-propyl-2,6-benzothiazolediamine Dihydrochloride Pramipexole Related Compound D (25 mg) ((R)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole) | Inhibitors;All Inhibitors;Pharmaceuticals;Chiral Reagents;Impurities-pramipexole;Sulfur & Selenium Compo;Sulfur & Selenium Compounds;Impurity reference substance;Intermediates & Fine Chemicals;Referen |
| 66 | 74065-63-7 | 6,6'-bis(hydroxymethyl)-2,2'-bipyridine | [2,2′-Bipyridine]-6,6′-dimethanol [2,2'-Bipyridine]-6,6'-diyldimethanol 6,6'-bis(hydroxymethyl)-2,2'-bipyridine 6,6′-bis(hydroxymethyl)-2,2′-bipyridine Methanone,[8-(hydroxymethyl)phenyl]phenyl- α-D-Glucopyranuronicacid,methylester,2,3,10-triacetate | Alcohol;Organic chemistry;Pyridine derivatives;Traditional Chinese medicine reference substance |
| 67 | 1335202-59-9 | 2-(4-(Sec-butoxy)-3-cyanophenyl)-4-methylthiazole-5-carboxylic acid | Febuxostat-10 Febuxostat Impurity 63 FeBuxostat Impurity 24 Febuxostat sec-Butoxy Acid (L) 4-(sec-butoxy)isophthalonitrile 2-(4-(sec-butoxy)-3-cyanophenyl)-4-methylthiazole-5-carboxylic aci 2-(4-(sec-butoxy)-3-cyanophenyl)-4-methylthiazole-5-carboxylic acid 2-(4-(Sec-butoxy)-3-cyanophenyl)-4-methylthiazole-5-carboxylic acid | Non-buxotan impurity;Impurity reference substance;Reference substance-impurity reference substance |
| 68 | 1271738-74-9 | Febuxostat Impurity 6 | Febuxostat-49 Febuxostat Impurity 6 Febuxostat Impurity 51 Febuxostat Impurity 6 (E) ethyl (E)-2-(3-((hydroxyimino)methyl)-4-isobutoxyphenyl)-4- methylthiazole-5-carboxylate ethyl 2-[3-((hydroxyimino)methyl)-4-(2-methylpropoxy)phenyl]-4-methylthiazole-5-carboxylate 2-[3-[(Hydroxyimino)methyl]-4-(2-methylpropoxy)phenyl]-4-methyl-5-Thiazolecarboxylic Acid Ethyl Ester 2-[3-[(HYDROXYIMINO)METHYL]-4-(2-METHYLPROPOXY)PHENYL]-4-METHYL-5-THIAZOLECARBOXYLIC ACID ETHYL ESTER | Hybrid;Series 1;Non-buxotan impurity;Impurity reference substance;Reference substance-impurity reference substance |
| 69 | 43153-07-7 | Rac 2-(4-Formylphenyl)propionic Acid | IBUPROFEN IMPURITY K 2-(p-Formylphenyl)propionic Acid 2-(4-formylphenyl)propanoic acid 4-Formyl-a-methylbenzeneacetic Acid Rac 2-(4-Formylphenyl)propionic Acid rac 2-(4-Formylphenyl)propionic Acid (2RS)-2-(4-FORMYLPHENYL)PROPANOIC ACID 2-(4-Formylphenyl)propionic acid - Racemic rac 2-(4-Formylphenyl)propionic Acid (Ibuprofen Impurity K) | Aromatics;Impurities;Pharmaceuticals;Ibuprofen impurity;Impurity reference substance;Intermediates & Fine Chemicals;Reference substance-impurity reference substance |
| 70 | 1239233-86-3 | 2-(3-Carbamoyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic acid | Febuxostat-1 Febuxostat Amide Febuxostat Impurity 4 (A) Febuxostat Related CoMpound Febuxostat Related Compound (Febuxostat Impurity 4 ) 2-(3-Carbamoyl-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic acid 2-[3-carbamoyl-4-(2-methylpropoxy)phenyl]-4-methyl-5-thiazole carboxylic acid 2-[3-(AMinocarbonyl)-4-(2-Methylpropoxy)phenyl]-4-Methyl-5-thiazolecarboxylic Acid | Standard substance;Febuxostat impurity;Impurity reference substance;Amino acid derivative compounds;Heterocycles, Impurities, Inhibitors, Pharmace;Reference substance-impurity reference substance;Hete |
| 71 | 210980-68-0 | Dehydro Simvastatin | SIMV-IM A Dehydro Simvastatin SiMvastatin IMpurity-C SiMvastatin EP IMpurity C Anhydro SiMvastatin (SiMvastatin IMpurity C) (1S,3R,7S,8S,8aR)-3,7-dimethyl-8-(2-((R)-6-oxo-3,6-dihydro-2H-pyran-2-yl)ethyl)-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate (1S,3R,7S,8S,8aR)-3,7-dimethyl-8-(2-((R)-6-oxo-5,6-dihydro-2H-pyran-2-yl)ethyl)-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate 2,2-DiMethylbutanoic Acid (1S,3R,7S,8S,8aR)-8-[2-[(2R)-3,6-Dihydro-6-oxo-2H-pyran -2-yl]ethyl]-1,2,3,7,8,8a-hexahydro-3,7-diMethyl-1-naphthalenyl Ester | Impurities;Chiral Reagents;Pharmaceuticals;168-simvastatin;Simvastatin impurity c;Impurity reference substance;Intermediates & Fine Chemicals |
| 72 | 56271-94-4 | [6R-[6alpha,7beta(Z)]]-7-[2-furyl(methoxyimino)acetamido]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | Einecs 260-086-2 Cefuroxime sodium impurity A Cefuroxime Sodium EP Impurity A Cefuroxime Sodium Impurity A (EP) (6R)-7α-[[2-Furanyl(methoxyimino)acetyl]amino]-3-hydroxymethyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid [6R-[6alpha,7beta(Z)]]-7-[2-furyl(methoxyimino)acetamido]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (6R-(6alpha,7beta(Z)))-7-(2-Furyl(methoxyimino)acetamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid (6R,7R)-7-[[(2Z)-2-(2-Furanyl)-2-(MethoxyiMino)acetyl]aMino]-3-(hydroxyMethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid | Standards;Impurities;Heterocycles;Pharmaceuticals;Controls-impurity controls;Sulfur & Selenium Compounds;Intermediates & Fine Chemicals;Chemical Impurities-cefuroxime sodium |
| 73 | 1956436-64-8 | Solifenacin IMpurity | Solifenacin IMP Solifenacin IMpurity Solifenacin Related Compound Solifenacin Related Compound 33 (R)-Quinuclidinyl Benzoyl Solifenacin Solifenacin Benzoyl (R)-Quinuclidinyl Impurity Carbamic acid, N-[2-(2-benzoylphenyl)ethyl]-, (3R)-1-azabicyclo[2.2.2]oct-3-yl ester Solifenacin iMpurity (4-nitrophenyl (1S)-1-phenyl-3-4-dihidroisoquinoline-2(1H)-carboxylate) | 215-solifenacin;Impurity control;Genitourinary system;Control-impurity control;New drug impurity analysis and detection |
| 74 | 22681-72-7 | alpha-(3,4-dihydroxyphenyl)lactic acid | alpha-Dhpla 2-(3,4-Dihydroxyphenyl)lactic acid alpha-(3,4-dihydroxyphenyl)lactic acid 2-(3,4-dihydroxyphenyl)-2-hydroxypropanoicaci Benzeneacetic acid, a,3,4-trihydroxy-a-methyl- Benzeneacetic acid, α,3,4-trihydroxy-α-methyl- 2-(3,4-Dihydroxyphenyl)-2-hydroxypropanoic acid Benzeneacetic acid, alpha,3,4-trihydroxy-alpha-methyl- | phytochemical;chemical reagent;Advantage product;Standard substance;Reference substance;Plant extract standard;Standard substance-ref;pharmaceutical intermediate;standardized herbal extract;Chinese me |
| 75 | 1424857-68-0 | 1-(4-Bromobutyl)-3,4-dihydro-7-hydroxy-2(1H)-quinolinone | Aripiprazole N-Bromobutyl Impurity 1-(4-Bromobutyl)-3,4-dihydro-7-hydroxy-2(1H)-quinolinone 2(1H)-Quinolinone, 1-(4-bromobutyl)-3,4-dihydro-7-hydroxy- | Chemical raw materials |
| 76 | 357189-95-8 | Posaconazole Impurity 43 | -Diformyl Posaconazole Impurity 43 Desethylene Posaconazole N,N'-Diformyl Posaconazole Desethylene Diformyl Impurity Desethylene Posaconazole N(triazolonophenyl)-Formyl N-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)-N-(2-(N-(4-(1-((2S,3S)-2-hydroxypentan-3-yl)-5-oxo-1H-1,2,4-triazol-4(5H)-yl)phenyl)formamido)ethyl)formamide N-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)-N-(2-(N-(4-(1-((2S,3S)-2-hydroxypentan-3-yl)-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl)phenyl)formamido)ethyl)formamide | Standard;Impurity control |
| 77 | 1789703-32-7 | Amoxicillin EP Impurity L | 6-APA Amoxicillin Amide Amoxicillin EP Impurity L Amoxicillin Related Compound L (2S,5R,6R)-6-[[[(2S,5R,6R)-6-[[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-yl]carbonyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid (2S,5R,6R)-6-[[(2S,5R,6R)-6-[[(2R)-2-Amino-2-(4-hydroxyphenyl)acetyl] amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carbonyl] amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 6-[[[(2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]hept-2-yl]carbonyl]amino]-3,3-dimethyl-7-oxo-, (2S,5R,6R)- | Amoxicillin impurity;Pharmaceutical raw materials;Impurity reference substance;Superior supply of amoxicillin |
| 78 | 124646-10-2 | Famotidine EP Impurity A | Famotidine EP Impurity A 3-(((2-guanidinothiazol-4-yl)methyl)thio)propanimidamide(WXG01090) Propanimidamide, 3-[[[2-[(aminoiminomethyl)amino]-4-thiazolyl]methyl]thio]- 3-[[[2-[(Diaminomethylidene)amino]thiazol-4-yl]methyl]sulfanyl]propanimidamide | |
| 79 | 1566599-01-6 | Cefotiam Impurity 2 | Ceftiam impurity 2 Cefotiam Impurity 2 4-Thiazoleacetamide, 2-amino-N-[(5aR,6R)-1,4,5a,6-tetrahydro-1,7-dioxo-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl]- 2-(2-aminothiazol-4-yl)-N-((5aR,6R)-1,7-dioxo-1,4,5a,6-tetrahydro-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl)acetamide | Impurity control |
| 80 | 1795129-59-7 | Formoterol EP Impurity F | Formoterol Dimer Formoterol EP Impurity F FormoterolEPImpurityFDiformate Formoterol Fumarate EP Impurity F Formamide, N-[2-hydroxy-5-[1-[[2-hydroxy-5-[1-hydroxy-2-[[2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]amino]-2-[[2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]- | Impurity;190-Formoterol;Impurity control;Control-impurity control |
| 81 | 87009-72-1 | Metronidazole Impurity 9 | Metronidazole Impurity 9 Metronidazole Benzoate Impurity 2-(2-Methyl-4-nitro-1H-imidazol-1-y Metronidazole impurity H (self-edited) 1H-Imidazole-1-ethanol, 2-methyl-4-nitro-, 1-benzoate | Impurity control |
| 82 | 189264-02-6 | Argatroban Impurity 26 | Argatroban-8 Argatroban Impurity 26 Argatroban Impurity B26 Argatroban Related Impurity Argatroban Related Impurity 2 Agatroban diastereomer mixture Argatroban Impurity 26 (Mixture of Diastereomers) Argatroban Related Impurity 2 (Mixture of Diastereomers) (2S,4R)-4-Methyl-1-(((3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonyl)-L-arginyl)piperidine-2-carboxylicacid | 065-Argatroban;Impurity control |
| 83 | 2098642-70-5 | Trillikamtoside Q | Trillikamtoside Q | Traditional Chinese Medicine control |
| 84 | 874760-71-1 | Lenalidomide Impurity 13 | Lenalidomide Impurity 20 Lenalidomide Impurity 13 Lenalidomide Impurity 48 Lenalidomide Impurity 31 Lenalidomide Impurity 0328 N-(1-oxo-4-nitroisoindolin-2-yl)-L-glutamine 2-(4-Nitro-1-oxoisoindolin-2-yl)-4-carbamoylbutanoic acid 2H-Isoindole-2-acetic acid, α-(3-amino-3-oxopropyl)-1,3-dihydro-4-nitro-1-oxo-, (αS)- | Hybridization;Drug impurity control |
| 85 | 1415488-05-9 | Paliperidone Impurity 7 | Paliperidone Impurity 7 Paliperidone Impurities6 Paliperidone Impurity 44 Hexadecanoic acid, 3-(2-chloroethyl)-6,7,8,9-tetrahydro-2-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-yl ester | |
| 86 | 1187966-93-3 | Pitavastatin Impurity 2 | Pitavastatin Impurity 2 Pitavastatin calcium impurity Pitavastatin Benzophenanthridine (3R,5S)-5-(6-cyclopropyl-10-fluorobenzo Pitavastatin Benzophenanthridine Impurity Benzo[k]phenanthridine-8-pentanoic acid, 6-cyclopropyl-10-fluoro-β,δ-dihydroxy-, (βR,δS)- (3R,5S)-5-(6-Cyclopropyl-10-fluorobenzo[k]phenanthridin-8-yl)-3,5-dihydroxypentanoic Acid 3-(3-((1S,3R)-4-carboxy-1,3-dihydroxybutyl)oxiran-2-yl)-2- cyclopropyl-4-(4-fluorophenyl)quinoline 1-oxide | Standard substance;Impurity control substance;Control substance-impurity control substance |
| 87 | 1797982-93-4 | Ganciclovir EP impurity A | Ganciclovir impurities818 Ganciclovir EP impurity A Ganciclovir EP impurity A -J Ganciclovir Impurity 1(Ganciclovir EP Impurity A) 2-amino-9-(((2-chloroallyl)oxy)methyl)-1H-purin-6(9H)-one 2-amino-9-(((2-chloroallyl)oxy)methyl)-1,9-dihydro-6H-purin-6-one 6H-Purin-6-one, 2-amino-9-[[(2-chloro-2-propen-1-yl)oxy]methyl]-1,9-dihydro- | 137-ganciclovir;Impurity control;Control-impurity control |
| 88 | 1364671-62-4 | 4-((3-chloro-4-methoxybenzyl)amino)-2-(methylthio)-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide | Avanafil-006 4-((3-chloro-4-methoxybenzyl)amino)-2-(methylthio)-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide 4-((3-chloro-4-methoxybenzyl)amino)-2-(methylthio)-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide Avanafil-006 | Control-impurity control |
| 89 | 849206-42-4 | Olmesartan Impurity 9 | Olmesartan Impurity 9 3,6-dihydro-6,6-dimethyl-2-propyl-4H-Furo[3,4-d]imidazol-4-one 4H-Furo[3,4-d]imidazol-4-one, 3,6-dihydro-6,6-dimethyl-2-propyl- | |
| 90 | 152567-80-1 | 2-(3-methylbutanoyl)benzoic acid | n-Butylphthalide-016 Butyphthalide Impurity Butyphthalide impurity16 3-Butylphthalide Impurity Butylphthalide Impurity 16 3-Butylphthalide Impurity 15 2-(3-methylbutanoyl)benzoic acid Benzoic acid, 2-(3-methyl-1-oxobutyl)- | Impurity control |
| 91 | 2169271-28-5 | (5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl) methanol | Vonoprazan-13 Vonoprazan-007 TAK438 Impurity 1 Vonoprazan Impuirty 10 VonoprazanImpurity16HCl 1H-Pyrrole-3-methanol, 5-(2-fluorophenyl)-1-(3-pyridinylsulfonyl)- (5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl) methanol 1-[(2-chloro-3-pyridinyl)sulfonyl]-5-(2-fluorophenyl)-1H-Pyrrole-3-carboxaldehyde | Impurity control;Vonoprazan impurity;Chemical intermediate |
| 92 | 131741-37-2 | Levosimendan Impurity 4 | Levosimendan Impurity 4 2-Amino-N-(4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)-2-oxoacetohydrazonoyl Cyanide Acetamide, 2-cyano-2-[2-[4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl]hydrazinylidene]- (E)-2-amino-N-(4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)-2-oxoacetohydrazonoyl cyanide | Watson catalog 2;Controls-impurity controls |
| 93 | 78712-80-8 | Ozagrel | Ozagrel 2-Propenoic acid, 3-[4-(1H-imidazol-1-ylmethyl)phenyl]-, ethyl ester, (2E)- | Impurity control |
| 94 | 2230270-03-6 | ethyl 2-(4-butoxy-3-formylphenyl)-4-methylthiazole-5-
carboxylate | Febuxostat-43 ethyl 2-(4-butoxy-3-formylphenyl)-4-methylthiazole-5- carboxylate | Impurity control |
| 95 | 2242008-37-1 | Dapoxetine impurity | Dapoxetine-002 Dapoxetine impurity 1-Propanone, 3-[4-[3-(dimethylamino)-3-phenylpropoxy]-1-naphthalenyl]-1-phenyl- (S)-3-(4-(3-(dimethylamino)-3-phenylpropoxy)naphthalen-1-yl)-1-phenylpropan-1-one D-tartrate | Control;Dapoxetine |
| 96 | 1083246-65-4 | Pregabalin Impurity 21 | Pregabalin Impurity 21 Pregabalin Impurity 40 3-((3-(aminomethyl)-5-methylhexanamido) (S)-3-(((S)-3-(aminomethyl)-5-methylhexanamido)methyl)-5-methylhexanoic acid Hexanoic acid, 3-[[[(3S)-3-(aminomethyl)-5-methyl-1-oxohexyl]amino]methyl]-5-methyl-, (3S)- | 066-pregabalin;Impurity control;Control-impurity control |
| 97 | 2073891-59-3 | ethyl 2-(3,5-diformyl-4-hydroxyphenyl)-4-methylthiazole-5- carboxylate | Febuxostat-005 ethyl 2-(3,5-diformyl-4-hydroxyphenyl)-4-methylthiazole-5- carboxylate Ethyl 2-(3,5-diformyl-4-hydroxyphenyl)-4-methyl-1,3-thiazole-5-carboxylate 5-Thiazolecarboxylic acid, 2-(3,5-diformyl-4-hydroxyphenyl)-4-methyl-, ethyl ester 2-?(3,?5-?Diformyl-?4-?hydroxyphenyl)?-?4-?methyl-5-?thiazolecarboxylic acid Ethyl Ester | Impurity control |
| 98 | 60853-66-9 | 2-(tert-butylamino)-1-(4-hydroxy-3-methylphenyl)ethan-1-one | Salbutamol Impurity 69 2-(tert-Butylamino)-1-(4-hydroxy-3-methylphenyl)ethanone 2-(tert-butylamino)-1-(4-hydroxy-3-methylphenyl)ethan-1-one | 125-Salbutamol |
| 99 | 896133-95-2 | Nicorandil Impurity 5 | Nicorandil Impurity 5 Nicorandil Impurity 36 Nicorandil Impurity 22 3-Pyridinecarboxamide, 1,6-dihydro-N-(2-hydroxyethyl)-6-oxo- | Watson custom catalog 1 |
| 100 | 107812-86-2 | Amlodipine Impurity 26 | Amlodipine Impurity 4 Amlodipine Impurity 26 Amlodipine Impurity 57 | Standard;Impurity control;Control-impurity control |
| 101 | 200628-33-7 | Rasagiline Impurity 2 | Rasagiline Impurity Rasagiline Impurity 2 | Impurity control |
| 102 | 2245197-07-1 | Dapoxetine-004 | Dapoxetine-004 Dapoxetine Impurity 75 Dapoxetine impurity 3 HCl 3-((4-cinnamylnaphthalen-1-yl)oxy)-N,N-dimethyl-1-phenylpropan-1-amine (S,E)-3-((4-cinnamylnaphthalen-1-yl)oxy)-N,N-dimethyl-1-phenylpropan-1-amine Benzenemethanamine, N,N-dimethyl-α-[2-[[4-(3-phenyl-2-propen-1-yl)-1-naphthalenyl]oxy]ethyl]- | Dapoxetine;Control substance;Impurity control substance |
| 103 | 1334703-07-9 | Zoledronic acid | Zoledronic acid Zoledronic Acid Impurity 8 | |
| 104 | 106649-96-1 | Famotidine EP Impurity H | Famotidine EP Impurity H Famotidine Impurity H(EP) QUBHCMPAOWIZMT-UHFFFAOYSA-N (2-(diaminomethyleneamino)thiazol-4-yl)methyl carbamimidothioate | Chemical impurity;Impurity reference substance |
| 105 | 58781-38-7 | Erythromycin Impurity 9 | Erythromycin Impurity 9 Erythromycin Impurity 13 Cycloester Erythromycin Enol Ether Erythromycin Impurity 9 (Cycloester Erythromycin Impurity 9 (Cycloester Erythromycin Enol Ether) Erythromycin, 8,9-didehydro-9-deoxo-6,9-epoxy-, cyclic 11,12-carbonate (9CI) | |
| 106 | 57736-10-4 | Parecoxib Impurity 4 | Parecoxib Imp.N Parecoxib Impurity 4 Parecoxib Impurity 63 Parecoxib Sodium Impurity 61 (Z)-1,2-Diphenylethanone oxime Ethanone, 1,2-diphenyl-, oxime, (1Z)- (NZ)-N-(1,2-diphenylethylidene)hydroxylamine | Impurity-parecoxib sodium |
| 107 | 198470-91-6 | Parecoxib ImpurityO | PARECOXIB SODIUM H Parecoxib ImpurityO parecoxib butyl amide impurity N-[[4-(5-Methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]butanamide N-((4-(5-methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)butyramide Butanamide, N-[[4-(5-methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]- N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)butyramide (Palbociclib Impurity) | Parecoxib sodium;Impurity control;Control-impurity control;Impurity-parecoxib sodium |
| 108 | 92850-02-7 | Rasagiline Dipropynyl HCl | Rasagiline Dipropynyl HCl RasagilineImpurity8Mesylate 2,3-Dihydro-N,N-di-2-propyn-1-yl-1H-inden-1-amine N,N-di(prop-2-yn-1-yl)-2,3-dihydro-1H-inden-1-amine 1H-Inden-1-amine, 2,3-dihydro-N,N-di-2-propyn-1-yl- | |
| 109 | 2240179-62-6 | Dexmedetomidine-004 | Dexmedetomidine-004 1H-Imidazole, 5-[1-(3,4-dimethylphenyl)ethyl]- | Impurity control;Watson spot catalog 2 |
| 110 | 297175-66-7 | Amoxicillin Impurity 3 | Amoxicillin Impurity 8 Amoxicillin Impurity 3 Amoxicillin Impurity 20 the Mixture of Dimers 1,2,3 ,4 of Amoxicillin Amoxicilloic Acid Dimer (Mixture of Diastereomers) Amoxicilloic amoxilloic acid dimers 1, 2, 3, and 4 Glycinamide, (2R)-2-(4-hydroxyphenyl)glycyl-(2R)-2-[(2S,4S)-4-carboxy-5,5-dimethyl-2-thiazolidinyl]glycyl-N-[[(2S,4S)-4-carboxy-5,5-dimethyl-2-thiazolidinyl]methyl]-2-(4-hydroxyphenyl)-, (2R)- (9CI) | Superior Supply of amoxicillin |
| 111 | 124635-86-5 | Flurbiprofen Impurity 6 | Flurbiprofen Impurity 6 Flurbiprofen 2-Glyceryl Ester Flurbiprofen axetil impurity2 Flurbiprofen axetil impurity1418 | Impurity control |
| 112 | 134429-33-7 | 6-alfa-Hydroxy Mometasone Furoate | Mometasone Furoate Impurity U Mometasone Furoate Impurity 20 6-alfa-Hydroxy Mometasone Furoate Mometasone Furoate 6alpha-Hydroxy Impurity Mometasone Furoate Impurity 25 (6α-Hydroxy mometasone furoate) Pregna-1,4-diene-3,20-dione, 9,21-dichloro-17-[(2-furanylcarbonyl)oxy]-6,11-dihydroxy-16-methyl-, (6α,11β,16α)- | Impurity control |
| 113 | 48103-74-8 | Lenalidomide Impurity 11 | L-Glutamic Anhydride Lenalidomide Impurity 11 (S)-3-aminodihydro-2H-pyran-2,6(3H)-dione 2H-Pyran-2,6(3H)-dione, 3-aminodihydro-, (3S)- | Drug impurity control |
| 114 | 1804915-68-1 | Avibactam Impurity 46 | WCK4234 WCK 4234 SODIUM Avibactam Impurity 46 sodium (2R,5R)-2-cyano-7-oxo-6-azabicyclo[3.2.1]octan-6-yl sulfate | Impurity control;Β-lactamase inhibitor;Control-impurity control |
| 115 | 2295862-29-0 | Lifitegrast Impurity 3 | Lifitegrast Impurity 3 (S)-methyl 2-(2-(benzofuran-6-carbonyl) methyl (S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoate | Standard;Impurity control |
| 116 | 2305949-36-2 | Dapagliflozin Impurity 9 | Dapagliflozin Impurity 9 1-chloro-2-(2-ethoxybenzyl)-4-iodobenzene Benzene, 1-chloro-2-[(2-ethoxyphenyl)methyl]-4-iodo- | Dapagliflozin;Impurity control;Control-impurity control;Impurity world-dapagliflozin |
| 117 | 2055542-18-0 | 1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethanol | Apremilast Impurity 66 1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethanol | Impurity control |
| 118 | 116218-80-5 | Iloperidone Impurity 31 | Iloperidone Impurity 31 Ethanone, 1-[3-methoxy-4-(2-propen-1-yloxy)phenyl]- | |
| 119 | 2338845-31-9 | Parecoxib Sodium EJF | Parecoxib Sodium EJF Parecoxib Impurity 01 Parecoxib Impurity 001 | Impurity;Impurity control;Control-impurity control;Impurity-parecoxib sodium |
| 120 | 2223677-64-1 | Afatinib Impurity des-EJA | Afatinib des-EJA Afatinib Impurity des-EJA Des(dimethylamino)-Afatinib (2E)-N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-2-butenamide 2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-, (2E)- (S,E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)but-2-enamide (Afatinib Impurity) | |
| 121 | 117152-72-4 | Plerixafor Impurity 7 | Plerixafor Impurity 7 1,4,8,11-Tetraazacyclotetradecane, 1,8-bis[(4-methylphenyl)sulfonyl]- | Control-impurity control |
| 122 | 2252446-69-6 | 1-cyclopropyl-8-fluoro-6-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid | Moxifloxacin EP Imp.D HCl Moxifloxacin Impurity D HCl Azilsartan medoxomil impurity288 1-cyclopropyl-8-fluoro-6-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid 1-cyclopropyl-8-fluoro-6-methoxy-7-((4aR,7aR)-octahydro-6H- pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride | |
| 123 | 21480-43-3 | Metaraminol Bitartrate Impurity 3 | Ephedrine Impurity 3 Metaraminol Impurity 27 M-hydroxyamine Diastereomers 1 Metaraminol bitartrate Impurity12 Metaraminol Bitartrate Impurity 3 (1R,2R)-1-(m-Hydroxyphenyl)-2-amino-1-propanol Benzenemethanol, α-[(1R)-1-aminoethyl]-3-hydroxy-, (αR)- | Impurity control |
| 124 | 253768-88-6 | Paroxetine Related Impurity 9 | Paroxetine impurities766 Paroxetine impurities767 N-Phenoxycarbonylparoxetine Paroxetine Related Impurity 9 (3S,4R)-3-((benzo[d][1,3]dioxol-4-yloxy)methyl)-4-(4-fluorophenyl)piperidine Phenyl (3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine-1-carboxylate (3S,4R)-phenyl 3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4- fluorophenyl)piperidine-1-carboxylate 1-Piperidinecarboxylic acid, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, phenyl ester, (3S,4R)- | Paroxetine |
| 125 | 1375090-19-9 | Lacosamide impurity 8/Lacosamide EP Impurity H/(S)-2-acetamido-N-((S)-1-(benzylamino)-3-methoxy-1-oxopropan-2-yl)-3-methoxypropanamide | Lacosamide Impurity 21 Lacosamide Impurity 12 Lacosamide EP Impurity H (SS-Isomer) L-Serinamide, N-acetyl-O-methyl-L-seryl-O-methyl-N-(phenylmethyl)- AMIDO-N-((S)-1-(BENZYLAMINO)-3-METHOXY-1-OXOPROPAN-2-YL)-3-METHOXYPROPANAMIDE (S)-2-Acetamido-N-((S)-1-(benzylamino)-3-methoxy-1-oxopropan-2-yl)-3-methoxypropanamide | Impurity control;Lacosamide impurity |
| 126 | 2095189-99-2 | Dapoxetine impurity 11/(S)-N-Didemethyl Dapoxetine HCl/(S)-α-[2-(1-Naphthalenyloxy)ethyl]benzenemethanamine Hydrochloride | N-Didesmethyl Dapoxetine Hydrochloride 3-(naphthalen-1-yloxy)-1-phenylpropan-1-amine hydrochloride | Control;Dapoxetine |
| 127 | 2432911-32-3 | Brivaracetam Impurity 3 | Brivaracetam Impurity 3 | Impurity control;Brivaracetam impurity |
| 128 | 2077897-93-7 | Apremilast Impurity HS093313 | Apremilast Impurity HS093313 (S)-2-(1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl) isoindoline-1,3-dione | 155-aprest;Control substance;Impurity control substance |
| 129 | 2083621-91-2 | MBM-17S | MBM-17S | Control |
| 130 | 618458-79-0 | 4-Amino-6-ethoxy-5-[[4-[(4R)-1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl]phenyl]azo]-α-[[4-[(4R)-1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl]phenyl]hydrazono]-2-pyrimidineacetonitrile | 4-Amino-6-ethoxy-5-[[4-[(4R)-1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl]phenyl]azo]-α-[[4-[(4R)-1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl]phenyl]hydrazono]-2-pyrimidineacetonitrile | Impurity control;Watson spot catalog 2 |
| 131 | 2452301-09-4 | Empagliflozin Methyl Acetate | Empagliflozin Methyl Acetate | 079-engliflozin;Impurity control |
| 132 | 1355648-15-5 | Flumethasone Impurity 6 (9-Chloro-Flumethasone) | Flumethasone Impurity 6 Flumethasone Impurity 6 (9-Chloro-Flumethasone) (6S,8S,9R,10S,11S,13S,14S,16R,17R)-9-chloro-6-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one | |
| 133 | 1414933-82-6 | 2,7,10,12-Tetraazatridecanoic acid, 4-hydroxy-12-methyl-9-(1-methylethyl)-13-[2-(1-methylethyl)-4-thiazolyl]-8,11-dioxo-3,6-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (3S,4R,6R,9S)- | RitovirEPImpurityQ 2,7,10,12-Tetraazatridecanoic acid, 4-hydroxy-12-methyl-9-(1-methylethyl)-13-[2-(1-methylethyl)-4-thiazolyl]-8,11-dioxo-3,6-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (3S,4R,6R,9S)- | Impurity control |
| 134 | 43067-01-2 | Dimethyl 4-(2-Chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate | AMlodipine EP IMpurity G AMlodipine IMpurity G (EP) dimethyl 4-(2-chlorophenyl) Amlodipine Besylate Impurity G 4-(2-Chlorophenyl)-3,5-di(Methoxycarbonyl)-2,6-diMethyl-1,4- dihydropyridine Dimethyl 4-(2-Chlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate 4-(2-Chlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid dimethyl ester 4-(2-Chlorophenyl)-1,4-dihydro-2,6-diMethyl-3,5-pyridinedicarboxylic Acid 3,5-DiMethyl Ester | Aromatics;Standards;Heterocycles;Intermediates;Pharmaceuticals;Impurity controls;Amlodipine impurities;Chemical raw materials;Controls-impurity controls;Pharmaceutical raw materials |
| 135 | 2053424-82-9 | isopropyl ((S)-((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)(phenoxy)phosphoryl)-D-alaninate | TAF-IM-A3 TAF Impurity 5 TAF Impurity 8 Tenofovir impurity 9 Tenofovir Alafenamide Impurity 8 isopropyl ((((1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)(phenoxy)phosphoryl)-D-alaninate isopropyl ((S)-((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)(phenoxy)phosphoryl)-D-alaninate (R)-isopropyl 2-(((S)-((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)(phenoxy)phosphoryl)amino)propanoate | Tenofovir alafenamine;Control-impurity control;Tenofovir alafenamine impurity;Tenofovir alafenamide impurity;045-tenofovir alafenac ammonia ester |
| 136 | 704910-89-4 | 2-[[(3,5-DiMethyl-2-pyridinyl)Methyl]thio]-6-Methoxy-1H-benziMidazole | Omeprazole impurity P Omeprazole Impurity 11 4-DesMethoxy OMeprazole Sulfide 2-[[(3,5-DiMethyl-2-pyridinyl)Methyl]thio]-6-Methoxy-1H-benziMidazole 2-[[(3,5-Dimethyl-2-pyridinyl)methyl]thio]-5-methoxy-1H-benzimidazole 2-(((3,5-dimethylpyridin-2-yl)methyl)thio)-5-methoxy-1H-benzo[d]imidazole 2-(((3,5-dimethylpyridin-2-yl)methyl)thio)-6-methoxy-1H-benzo[d]imidazole | Pharmaceuticals;Impurity controls;Metabolites & Impurities;Metabolites & commodities;Mediates & Fine Chemicals;Controls-impurity controls;Sulfur & Selenium Compounds;Intermediates & Fine Chemicals |
| 137 | 383910-24-5 | Peramivir Impurity | Peramivir Impurity Peramivir impurities6 methyl (3aR,4S,6R,6aS)-6-((tert-butoxycarbonyl)amino)-3-(pentan-3-yl)-3a,5,6,6a-tetrahydro-4H-cyclopenta[d]isoxazole-4-carboxylate 4H-Cyclopent[d]isoxazole-4-carboxylic acid, 6-[[(1,1-dimethylethoxy)carbonyl]amino]-3-(1-ethylpropyl)-3a,5,6,6a-tetrahydro-, methyl ester, (3aR,4S,6R,6aS)- | Impurity control;Peramivir impurity;Control-impurity control |
| 138 | 2124296-37-1 | Peramivir Impurity 6 | Peramivir Impurity 6 Peramivir impurities10 (1S,2S,3R,4R)-3-((R)-1-acetamido-2-ethylbutyl)-4-guanidino-2-hydroxycyclopentane-1-carboxylic acid Cyclopentanecarboxylic acid, 3-[(1R)-1-(acetylamino)-2-ethylbutyl]-4-[(aminoiminomethyl)amino]-2-hydroxy-, (1S,2S,3R,4R)-rel- | Control-impurity control |
| 139 | 1315481-36-7 | (6R,7S)-7-[[(2R)-2-[[(4-Ethyl-2,3-dioxo-1-piperazinyl)carbonyl]aMino]-2-(4-hydroxyphenyl)acetyl]aMino]-3-[[(1-Methyl-1H-tetrazol-5-yl)thio]Methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid | (6R,7S)-Cefoperazone Cefoperazone Impurity (6R,7S)-Cefoperazone-d4 Cefoperazone EP Impurity F Cefoperazone Impurity 6(Cefoperazone EP Impurity F) (6R,7S)-7-[[(2R)-2-[[(4-Ethyl-2,3-dioxo-1-piperazinyl)carbonyl]aMino]-2-(4-hydroxyphenyl)acetyl]aMino]-3-[[(1-Methyl-1H-tetrazol-5-yl)thio]Methyl]-8-o (6R,7S)-7-[[(2R)-2-[[(4-Ethyl-2,3-dioxo-1-piperazinyl)carbonyl]aMino]-2-(4-hydroxyphenyl)acetyl]aMino]-3-[[(1-Methyl-1H-tetrazol-5-yl)thio]Methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid | Heterocycles;Chiral Reagents;Pharmaceuticals;Impurity controls;Controls-impurity controls;Sulfur & Selenium Compounds;Intermediates & Fine Chemicals;Cefoperazone sodium impurity advantage supply |
| 140 | 120418-76-0 | N-(2-Amino-2-oxoethyl)-N-[(2S)-2-(3,5-dioxo-1-piperazinyl)propyl]-glycine | Dexrazoxane imputity 3 Dexrazoxane imputity 4 Dexrazoxane Impurity 6 Dexrazoxane Imputity B N-(2-Amino-2-oxoethyl)-N-[(2S)-2-(3,5-dioxo-1-piperazinyl)propyl]-glycine Glycine, N-(2-amino-2-oxoethyl)-N-[(2S)-2-(3,5-dioxo-1-piperazinyl)propyl]- (S)-2-((2-amino-2-oxoethyl)(2-(3,5-dioxopiperazin-1-yl)propyl)amino)aceticacid | Impurity control |
| 141 | 18910-68-4 | Levalbuterol Related Compound B (20 mg) (alpha-[{(1,1-Dimethylethyl)amino}methyl]-4-hydroxy-3-methyl-benzenemethanol) | 3-Dehydroxy SalbutaMol Salbutamol EP Impurity C Levalbuterol Related CoMpound B Levalbuterol RC B ( Salbutamol EP Impurity C) 4-[2-(tert-butylamino)-1-hydroxyethyl]-2-methylphenol 4-[2-[(1,1-Dimethylethyl)amino]-1-hydroxyethyl]-2-methylphenol α-[[(1,1-dimethylethyl)amino]methyl]-4-hydroxy-3-methyl-Benzenemethanol Levalbuterol Related Compound B (20 mg) (alpha-[{(1,1-Dimethylethyl)amino}methyl]-4-hydroxy-3-methyl-benzenemethanol) | Salbutamol;089-salfenamide;Impurity control;Salbutamol EP impurity;Chemical impurity-salbutamol;Amines, Aromatics, Pharmaceuticals, mediates & Fine Chemicals;Amines, Aromatics, Pharmaceuticals, Interm |
| 142 | 147404-76-0 | Azilsartan iMpurity A | Azilsartan iMpurity A 1-((2'-carboxaMidebiphenyl-4-yl) Methyl)-2-ethoxy-1H-benziMidazole-7- carboxylic acid ethyl 1-((2'-carboxaMidebiphenyl-4-yl) Methyl)-2-ethoxy-1H-benziMidazole-7-carboxylate Methyl 1-((2'-carboxaMidebiphenyl-4-yl) Methyl)-2-ethoxy-1H-benziMidazole-7-carboxylate methyl 1-((2'-carbamoyl-[1,1'-biphenyl] -4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate 1-[[2'-(Aminocarbonyl)[1,1'-biphenyl]-4-yl]methyl]-2-ethoxy-1H-benzimidazole-7-carboxylic acid methyl ester Ethyl 1-[((2'-(2,5-dihydro-5-oxo-1,2,4- xadiazol-3-yl)biphenyl)-4-yl)Methyl]-2H-benziMidazol-2-one -7- carboxylate Methyl 1-[((2'-(2,5-dihydro-5-oxo-1,2,4- xadiazol-3-yl)biphenyl)-4-yl)Methyl]-2H-benziMidazol-2-one -7- carboxylate | Azilsartan;Heterocycles;019-azilsartan;Impurity control;Cardio-cerebral vessels and blood |
| 143 | 1255644-71-3 | Irinotecan Impurity 18 | (R)-Irinotecan Irinotecan Impurity 18 | |
| 144 | 1373038-60-8 | Valdecoxib IMpurity B | Valdecoxib DiMer Valdecoxib IMpurity B Parecoxib Sodium Impurity 13 Valdecoxib DiMer,Valdecoxib IMpurity B Valdecoxib IMpurity-B(valdecoxib DiMer) N-[4-(5-Methyl-3-phenyl-4-isoxazolyl)benzenesulfonyl]-4-(5-Methyl-3-phenyl-4-isoxazolyl)benzenesulfonaMide 4-(5-methyl-3-phenylisoxazol-4-yl)-N-((4-(5-methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)benzenesulfonamide BenzenesulfonaMide, 4-(5-Methyl-3-phenyl-4-isoxazolyl)-N-[[4-(5-Methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]- | Amines;Atomics;Impacts;Aromatics;Impurities;Heterocyces;Heterocycles;pharmaceutic;Pharmaceuticals;Impurity control |
| 145 | 1148113-53-4 | (R,R,R)-Aprepitant | Aprepitant A (R,R,R)-Aprepitant Aprepitant EP Impurity E Aprepitant trans-1-enantiomer Aprepitant Related CoMpound A Aprepitant USP RC A (R,R,R-Diasteromer) 5-[[(2R,3R)-2-[(1R)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-Morpholinyl]Methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one Aprepitant Related Compound A (10 mg) (3-[[(2R,3R)-2-[(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholino]methyl]-1H-1,2,4-triazol-5(4H)-one) | Heterocyces;Heterocycles;Chiral Reagents;Pharmaceuticals;Mediates & Fine Chemicals;Controls-impurity controls;Intermediates & Fine Chemicals |
| 146 | 73058-37-4 | N-Pyrazinylcarbonyl-L-phenylalanine Methyl Ester | Bortezomib Imp.F Bortezomib Impurity R Bortezomib Acid Methyl Ester N-PYRAZINYLCARBONYLPHENYLALANINE METHYL ESTER N-Pyrazinylcarbonyl-L-phenylalanine Methyl Ester methyl 3-phenyl-2-(pyrazine-2-carbonylamino)propanoate (S)-methyl 3-phenyl-2-(pyrazine-2-carboxamido)propanoate 3-Phenyl-2-[(pyrazine-2-carbonyl)-amino]-propionic Acid Methyl Ester | Aromatics;Impurity controls;Amino Acids 13C, 2H, 15N;Amino Acids & Derivatives |
| 147 | 1256966-04-7 | Tedizolid IMpurity | Tedizolid IMpurity tedizolid iMpurities Tedizolid Impurity 1 Tedizolid Impurity 9 Tedizolid Impurity 8 Tedizolid Impurity 10 Tedizolid Impurity 12 Tedizolid Impurity 14 Imidazolium Salt | Anti-infection;Impurity control;Impurity, control |
| 148 | 198470-82-5 | N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)isobutyraMide | Parecoxib-010 PARECOXIB SODIUM I Parecoxib Sodium Impurity 80 N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)isob... N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)isobutyraMide 2-Methyl-N-[[4-(5-methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]propanamide PropanaMide, 2-Methyl-N-[[4-(5-Methyl-3-phenyl-4-isoxazolyl)phenyl]sulfonyl]- | Drug impurity;Parecoxib sodium;Impurity control;Control-impurity control;Impurity-parecoxib sodium |
| 149 | 1185503-48-3 | (2R,3S)-2-[(1S)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(4-fluorophenyl)Morpholine hydrochloride | Fosaprepitant Impurity 31 Aprepitant intermediate 1 Aprepitant Impurity 12 HCl Aprepitant intermediate 1 HCl Arepitam intermediate 1 hydrochloride Des-1,2,4-triazol-3-one-5-methyl (2S,3R,1'R)-Aprepitant Morpholine, 2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-, (2S,3R)- (2R,3S)-2-[(1S)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(4-fluorophenyl)Morpholine hydrochloride | Control-impurity control |
| 150 | 21829-26-5 | diethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | Nifedipine-5 Nifedipine Impurity E Azilsartan medoxomil impurity302 diethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3... diethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-, 3,5-diethyl ester | Nifedipine |
| 151 | 548774-53-4 | Fludarabine Phosphate EP Impurity C | Fludarabine EP impurity C Fludarabine Phosphate Impurity 3 Fludarabine Phosphate EP Impurity C 9-(3,5-Di-O-phosphono-β-D-arabinofuranosyl)-2-fluoro-9H-purin-6-amine 9H-Purin-6-amine, 9-(3,5-di-O-phosphono-β-D-arabinofuranosyl)-2-fluoro- | Standard;Impurity control;Control-impurity control;Fludarabine phosphate impurity |
| 152 | 1396607-35-4 | Clopidogrel EP Impurity B HCl | Clopidogrel EP Impurity B HCl Clopidogrel EP Impurity B Hydrochloride | Control-impurity control |
| 153 | 81402-53-1 | 3-chloro-N,N-dimethyl-1-phenylpropan-1-amine hydrochloride | 3-chloro-N,N-dimethyl-1-phenylpropan-1-amine 3-chloro-N,N-dimethyl-1-phenylpropan-1-amine hydrochloride | Control |
| 154 | 1318074-22-4 | (3aR,4R,7S,7aS)-2-(((1R,2S)-2-((4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)Methyl)cyclohexyl)Methyl)hexahydro-1H-4,7-Methanoisoindole-1,3(2H)-dione | lurasidone-11 (3aR,4R,7S,7aS)-2-(((1R,2S)-2-((4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)Methyl)cyclohexyl)Methyl)hexahydro-1H-4,7-Methanoisoindole-1,3(2H)-dione | 088-Lurasidone;Impurity control;Lurasidone impurity |
| 155 | 10403-00-6 | (R)-(-)-MUSCONE | (R)-(-)-MUSCONE Cyclopentadecanone, 3-methyl-, (3R)- L-Muscone,R-(-)3-methy-cyclo pentadecanone | Drug Substance;Reference substance |
| 156 | 10211-88-8 | (3β,20S)-20-Formyl-3-hydroxy-5-pregnene 3-O-Acetate | 3β-Acetoxybisnor-5-cholen-22-al 3β-Acetoxy-22,23-dinorchol-5-en-24-al (20S)-3β-Acetoxypregn-5-ene-20-carboxaldehyde (20S)-3beta-Acetoxypregn-5-ene-20-carboxaldehyde (3β,20S)-20-Formyl-3-hydroxy-5-pregnene 3-O-Acetate (3β,20S)-3-(Acetyloxy)pregn-5-ene-20-carboxaldehyde Pregn-5-ene-20-carboxaldehyde, 3-(acetyloxy)-, (3β,20S)- (3β,20S)-20-ForMyl-3-hydroxy-5-pregnene 3-O-Acetate Discontinued | Steroids;Pharmaceuticals;Intermediates & Fine Chemicals;Steroids, Pharmaceuticals, Intermediates & Fine Chemicals |
| 157 | 50587-95-6 | 17-deacetylvecuronium | 17-deacetylvecuronium Vecuronium EP Impurity E Vecuronium Bromide EP Impurity E VecuroniuM BroMide Related CoMpound B Vecuronium bromide related substance B Vecuronium Bromide Impurity 5(Vecuronium Bromide EP Impurity E) 1-[(2β,3α,5α,16β,17β)-3-(Acetyloxy)-17-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-MethylpiperidiniuM BroMide 1-[(2beta,3alpha,5alpha,16beta,17beta)-3-(Acetyloxy)-17-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methylpiperidinium bromide | Impurity controls;Heterocyces, Pharmaceuticals, mediates & Fine Chemicals, Steroids;Heterocycles, Pharmaceuticals, Intermediates & Fine Chemicals, Steroids |
| 158 | 1426953-21-0 | Thailanstatin A | Thailanstatin A Thailandstatin A 1,6-Dioxaspiro[2.5]octane-5-acetic acid, 7-[(1E,3E)-5-[(2S,3S,5R,6R)-5-[[(2Z,4S)-4-(acetyloxy)-1-oxo-2-penten-1-yl]amino]tetrahydro-3,6-dimethyl-2H-pyran-2-yl]-3-methyl-1,3-pentadien-1-yl]-8-hydroxy-, (3R,5S,7R,8R)- | ADC;Pharmaceutical raw materials |
| 159 | 176168-78-8 | cis-Terbinafine Hydrochloride | (Z)-Terbinafine Terbinafine Impurity B HCl cis-Terbinafine Hydrochloride Terbinafine Related CoMpound B (Z)-N,6,6-trimethyl-N-(naphthalen-1-ylmethyl)hept-2-en-4-yn-1-amine,hydrochloride (2Z)-N,6,6-Trimethyl-N-(naphthalen-1-ylmethyl)hept-2-en-4-yn-1-amine hydrochloride N-[(2Z)-6,6-DiMethyl-2-hepten-4-yn-1-yl]-N-Methyl-1-naphthaleneMethanaMine Hydrochloride Terbinafine Related Compound B (25 mg) ((2Z)-N,6,6-Trimethyl-N-(naphthalen-1-ylmethyl)hept-2-en-4-yn-1-amine hydrochloride) | Amines;Aromatics;Terbinafine;Pharmaceuticals;Mediates & Fine Chemicals;Pharmaceutical raw materials;Intermediates & Fine Chemicals |
| 160 | 1408238-40-3 | Dabigatran Impurity 8 | Dabigatran Impurity 8 Dabigatran etexilate-4 Dabigatran etexilate-009 Dabigatran Ester Impurity C Dabigatran Impurity 7 (DABRC-07) Desiminomethyl Carbonyl Dabigatran Etexilate N-[[2-[[[4-[[[(HEXYLOXY)CARBONYL]AMINO]CARBONYL]PHENYL]AMINO]METHYL]-1-METHYL-1H-BENZIMIDAZOL-5-YL]CARBONYL]-N-2-PYRIDINYL-Β-ALANINE ETHYL ESTER ethyl 3-[[[2-[[[4-[[[(hexyloxy)carbonyl]amino]carbonyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl](pyridin-2-yl)amino]propanoate N-[[2-[[[4-[[[(Hexyloxy)carbonyl]amino]carbonyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-beta-alanine ethyl ester | Impurities;benzimidazol;impurity controls;Dabigatran impurity;Organic intermediates;Controls-impurity controls;Impurities-Dabigatran impure |
| 161 | 1190105-66-8 | 2-Pyrrolidinyl-3-acetyl Desmorpholinylrocuronium Bromide | Rocuronium impurity F SRMGVJLZFIUKGN-PWXDFCLTSA-M RocuroniuM broMide EP iMpurity F Rocuronium Bromide EP Impurity F Bromide 1-allyl-1-((2S,3S,5S,8R,9S,10S,13S,14S,16S,17R) 2-Pyrrolidinyl-3-acetyl Desmorpholinylrocuronium Bromide 1-[3α,17β-acetoxy-2β-(pyrrolidin-1-yl)-5α-androstan-16β-yl]-1-(prop-2-enyl)pyrrolidinium Bromide | Control;Impurity control;Impurity standard;Rocuronium impurity;Control-impurity control |
| 162 | 6992-30-9 | 1,2-Dithiolane-3-pentanoic acid 1-oxide | Protogen-B Thioctic Acid Impurity 8 Thioctic acid Impurity 3 Rac-Lipoic Acid Impurity E rac-Lipoic Acid Impurity 2 (S-Oxide) 5-(1-oxodithiolan-3-yl)pentanoic acid 1,2-Dithiolane-3-pentanoic acid 1-oxide 5-(1-oxido-1,2-dithiolan-3-yl)pentanoic acid | Control substance;Impurity control substance;Control substance-impurity control substance |
| 163 | 2179080-15-8 | Hexanenitrile, 3-(hydroxymethyl)-, (3R)- | Brivaracetam Impurity 65 (R)-3-(hydroxymethyl)hexanenitrile Hexanenitrile, 3-(hydroxymethyl)-, (3R)- | Impurity control;Brivaracetam impurity |
| 164 | 959042-70-7 | 2-Thiazolamine, 4-(4,5-dichloro-2-thienyl)- | Avatrombopag Impurity 20 2-Thiazolamine, 4-(4,5-dichloro-2-thienyl)- | Impurity control |
| 165 | 2287518-97-0 | 2,4(1H,3H)-Pyrimidinedione, 6-(3-aminopropoxy)-1,3-dimethyl- | 2,4(1H,3H)-Pyrimidinedione, 6-(3-aminopropoxy)-1,3-dimethyl- | Urapidil impurity |
| 166 | 1243654-85-4 | Pentoxifylline Impurity | Pentoxifylline Impurity PentoxifyllineImpurity10 Pentoxifylline Impurity 16 | |
| 167 | 70486-28-1 | 1H-Imidazole-5-carboxamide, 1-methyl-4-(methylamino)-N-(5-oxohexyl)- | Pentoxifylline Impurity PentoxifyllineImpurity8 Pentoxifylline Impurity 14 1H-Imidazole-5-carboxamide, 1-methyl-4-(methylamino)-N-(5-oxohexyl)- | |
| 168 | 84321-40-4 | 1H-Imidazole-5-carboxylic acid, 1-methyl-4-[methyl[[(5-oxohexyl)amino]carbonyl]amino]- | PentoxifyllineImpurity9 Pentoxifylline Impurity 13 Pentoxifylline Impurity 15 1H-Imidazole-5-carboxylic acid, 1-methyl-4-[methyl[[(5-oxohexyl)amino]carbonyl]amino]- | |
| 169 | 2096992-10-6 | β-Alanine, N-[[2-[[[4-[[[(2-ethylbutoxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, methyl ester | (Z)-ethyl 3-(2-(((4-(N'-((2-ethylbutoxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate β-Alanine, N-[[2-[[[4-[[[(2-ethylbutoxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, methyl ester | Impurity-dabigatran group |
| 170 | 1415385-39-5 | 2H-Cyclopenta[b]furan-2-one, hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-, (3aR,4R,5R,6aS)- | travoprost impurity Travoprost impurity5 2H-Cyclopenta[b]furan-2-one, hexahydro-5-hydroxy-4-[(1E,3S)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]-, (3aR,4R,5R,6aS)- | |
| 171 | 34646-56-5 | 3-(2-Naphtyloxy)-1,2-propanediol | 3-(2-Naphtyloxy)propane-1,2-diol 3-(2-Naphtyloxy)-1,2-propanediol 3-(2-Naphthalenyloxy)-1,2-propanediol 1,2-Propanediol, 3-(2-naphthalenyloxy)- | Impurity control |
| 172 | 58001-19-7 | Ergoline-8-methanol, 10-methoxy-1,6-dimethyl-, 8-(5-bromo-3-pyridinecarboxylate), (8α)- | Isonicergoline Ergoline-8-methanol, 10-methoxy-1,6-dimethyl-, 8-(5-bromo-3-pyridinecarboxylate), (8α)- ((6aR,9S,10aS)-10a-methoxy-4,7-dimethyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinolin-9-yl)methyl 5-bromonicotinate | Impurity control |
| 173 | 2084828-53-3 | UFFLDXFQXNYZLF-BHRSBNONSA-N | Ritonavir Impurity S Ritonavir Impurity 19 UFFLDXFQXNYZLF-BHRSBNONSA-N Ritonavir impurity reference ep-S Thiazol-5-yl-methyl [(1S,2S,4S)-1-benzyl-4-[[(2S)-2[[[(1S,3S,4S)-1-benzyl-3-hydroxy-5-phenyl-4-[[(thiazol-5-ylmethoxy)carbonyl]amino]pentyl]carbamoyl] amino]-3-methylbutanoyl]amino]-2-hydroxy-5-phenylpentyl]carbamate | Impurity control |
| 174 | 2137823-20-0 | 2(1H)-Quinolinone, 7-[4-(4-benzo[b]thien-4-yl-1-piperazinyl)butoxy]-1-[4-(4-benzo[b]thien-4-yl-1-piperazinyl)butyl]- | 2(1H)-Quinolinone, 7-[4-(4-benzo[b]thien-4-yl-1-piperazinyl)butoxy]-1-[4-(4-benzo[b]thien-4-yl-1-piperazinyl)butyl]- 7-(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)-1-(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butyl)quinolin-2(1H)-one 7-(4-(4-(benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)-1-(4-(4-(benzo [b]thiophen-4-yl)piperazin-1-yl)butyl)quinolin-2(1H)-one dihydrochloride | 174-eplipizole |
| 175 | 70474-97-4 | 4-(3,4-Dihydro-4,4-dimethyl-7-pentylfuro[4,3,2-de][1]benzopyran-3-yl)-2-butanone | Cannabicoumaronone 4-(3,4-Dihydro-4,4-dimethyl-7-pentylfuro[4,3,2-de][1]benzopyran-3-yl)-2-butanone | Traditional Chinese Medicine control |
| 176 | 2808-33-5 | 2-(3,7-Dimethyl-2,6-octadienyl)-5-pentyl-1,3-benzenediol | 2-(3,7-Dimethyl-2,6-octadienyl)-5-pentylresorcinol 2-(3,7-Dimethyl-2,6-octadienyl)-5-pentyl-1,3-benzenediol | Traditional Chinese Medicine control |
| 177 | 5767-82-8 | Pregn-16-en-20-one, 3,12-bis(acetyloxy)-, (3β,5α,12α)- | Pregn-16-en-20-one, 3,12-bis(acetyloxy)-, (3β,5α,12α)- | Control |
| 178 | 2489212-72-6 | Linagliptin N,N'-Methylene Dimer | Linagliptin N,N'-Methylene Dimer 8,8'-((3R,3'R)-(methylenebis(azanediyl))bis(piperidine-3,1-diyl))bis(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione) | 044-linagliptin |
| 179 | 2029195-97-7 | Benzamide, 4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-5,5-dimethyl-4-oxo-1-imidazolidinyl]-2-fluoro-N-methyl- | EnzalutamideImpurity47 Enzalutamide Impurities4 Enzalutamide Impurity 39 Enzalutamide Impurities749 4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-2-hydroxy-5,5-dimethyl-4-oxoimidazolidin-1-yl)-2-fluoro-N-methylbenzamide Benzamide, 4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-5,5-dimethyl-4-oxo-1-imidazolidinyl]-2-fluoro-N-methyl- | 181-enzalutamide |
| 180 | 93788-48-8 | 3-Butenoic acid, 2-diazo-3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-, (4-nitrophenyl)methyl ester | Imipenem Impurity 13 Imipenem intermediate 2 3-Butenoic acid, 2-diazo-3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-, (4-nitrophenyl)methyl ester | Impurity control;Standard/control/chemical reagent/experiment |
| 181 | 85604-01-9 | Imipenem Impurity 4 | Imipenem Impurity 4 Imipenem Impurity 7 1-Azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid, 3-[[2-[[[[2-[[2-carboxy-6-(1-hydroxyethyl)-7-oxo-1-azabicyclo[3.2.0]hept-2-en-3-yl]thio]ethyl]amino]methylene]amino]ethyl]thio]-6-(1-hydroxyethyl)-7-oxo-, [5R-[3[5R*,6S*(R*)],5α,6α(R*)]]- (9CI) | Impurity control;Standard/control/chemical reagent/experiment |
| 182 | 2484719-15-3 | Pyridine, 3-[3-(1-methylethoxy)androsta-5,16-dien-17-yl]- | Abiraterone Impurity 08 Abiraterone impurities426 Pyridine, 3-[3-(1-methylethoxy)androsta-5,16-dien-17-yl]- | Control;142-abiraterone acetate |
| 183 | 863-39-8 | (3R,5R,7R,8R,9S,10R,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-17-[(] | Trihydroxycoprostanoic acid 3,7,12-trihydroxycoprostanic acid Cholestane-5-carboxylic acid, 3,7,12-trihydroxy-, (3α,5β,7α,12α)- (3R,5R,7R,8R,9S,10R,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-17-[(] | Control |
| 184 | 2304005-44-3 | Erlotinib Impurity 48 | Erlotinib Impurity 48 Benzenamine, 3-(2-bromoethenyl)- Erlotinib Hydrochloride iMpurity 48 | Control-impurity control |
| 185 | 7443-29-0 | Heptanoic acid, 7-bromo-2,2-dimethyl- | Bempedoic Acid Impurity 13 Heptanoic acid, 7-bromo-2,2-dimethyl- | |
| 186 | 952680-48-7 | Carbamic acid, N-[3-fluoro-4-(4-morpholinyl)phenyl]-, 1,1-dimethylethyl ester | Carbamic acid, N-[3-fluoro-4-(4-morpholinyl)phenyl]-, 1,1-dimethylethyl ester | Impurity control |
| 187 | 52335-34-9 | Acetamide, N-(2-benzoyl-4-nitrophenyl)-2,2-dichloro- | N-(2-BENZOY-4-NITROPHENY)2.2-DICHLOROACETAMID Acetamide, N-(2-benzoyl-4-nitrophenyl)-2,2-dichloro- | Impurity control |
| 188 | 110578-70-6 | 1,2,4-Oxadiazole-3-carboxamide, N-(3-chloro-2-hydroxypropyl)-5-methyl- | ORNIDAZOLE IMPURITY 16 1,2,4-Oxadiazole-3-carboxamide, N-(3-chloro-2-hydroxypropyl)-5-methyl- | Impurity control |
| 189 | 42947-63-7 | (4S)-2-(((R)-2-Amino-2-(4-hydroxyphenyl)acetamido)(carboxy)-methyl)-5,5-dimethylthiazolidine-4 | Amoxicillin Related Impurity D (4S)-2-(((R)-2-Amino-2-(4-hydroxyphenyl)acetamido)(carboxy)-methyl)-5,5-dimethylthiazolidine-4 | Amoxicillin impurity |
| 190 | 211915-00-3 | Dabigatran iMpurity J | Dabigatran iMpurity J Dabigatran etexilate-15 Dabigatran etexilate-008 Dabigatran Impurity 9 (DABRC-09) methyl (E)-3-(2-(((4-(N'-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate β-Alanine, N-[[2-[[[4-[[[(hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, methyl ester methyl (Z)-3-(2-(((4-(N'-((hexyloxy)carbonyl)carbamimidoyl)phenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate Β-?ALANINE, N-?[[2-?[[[4-?[[[(HEXYLOXY)?CARBONYL]?AMINO]?IMINOMETHYL]?PHENYL]?AMINO]?METHYL]?-?1-?METHYL-?1H-?BENZIMIDAZOL-?5-?YL]?CARBONYL]?-?N-?2-?PYRIDINYL-?, METHYL ESTER | Control;benzimidazol;Dabigatran impence;Dabigatran impurity;Control-impurity control;impurity-dabigatatexilate |
| 191 | 1978305-26-8 | D-threo-Pentitol, 2,5-anhydro-1,3,4-trideoxy-2-C-(4-fluorophenyl)-4-(hydroxymethyl)-1-(1H-1,2,4-triazol-1-yl)- | PosacozoleImpurity85 Posaconazole Impurity 164 D-threo-Pentitol, 2,5-anhydro-1,3,4-trideoxy-2-C-(4-fluorophenyl)-4-(hydroxymethyl)-1-(1H-1,2,4-triazol-1-yl)- | Standard |
| 192 | 16156-94-8 | 2-[2-(2-Methyl-5-nitroiMidazol-1-yl)ethoxy]ethanol | Metronidazole IMpurity F Metronidazole EP Impurity F O-Hydroxyethyl Metronidazole Metronidazole impurity F (EP) 2-[2-(2-Methyl-5-nitroiMidazol-1-yl)ethoxy]ethanol 2-[2-(2-Methyl-5-nitro-1H-iMidazol-1-yl)ethoxy]ethanol Ethanol,2-[2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethoxy]- | Impurity control;170-metronidazole;Control-impurity control |